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Background 
Smoking prevalence is extremely high in adults experiencing homelessness and there is little evidence 
regarding which cessation interventions work best. This study explored the feasibility of providing free 
e-cigarette (EC) starter kits to smokers accessing homeless centres in the UK  
 
Objectives 
Seven key objectives were examined to inform a future trial. 1: Assess willingness of smokers to 
participate in the study to estimate recruitment rates. 2: Assess participant retention in the 
intervention and control groups. 3: Examine the perceived value of the intervention, facilitators and 
barriers to engagement and influence of local context. 4: Assess service providers’ capacity to support 
the study and the type of information and training required. 5: Assess the potential efficacy of 
supplying free EC starter kits. 6: Explore the feasibility of collecting data on contact with health care 
services as an input to a main economic evaluation. 7: Estimate the cost of providing the intervention 
and usual care. 
 
Design  
A prospective cohort four-centre pragmatic cluster feasibility study with embedded qualitative 
process evaluation.  
 
Setting  
Four homeless centres. Two residential units in London, England. One day centre in Northampton, 
England. One day centre in Edinburgh, Scotland.  
 
Intervention 
Intervention arm: A single refillable EC was provided with e-liquid provided once a week for four weeks 
(choice of three flavours: fruit, menthol, tobacco and two nicotine strengths: 12mg/mL or 18mg/mL). 
Written information for EC use and support. Usual care arm: Written information on quitting smoking 
(adapted from NHS Choices) and signposting to the local stop smoking service (SSS). 
 
Results  
Fifty-two percent of eligible participants invited to take part in the study were successfully recruited 
(56% in the EC arm; 50.5% in the UC arm; total N=80). Retention rates were 75%, 63% and 59% 
respectively at 4, 12 and 24 weeks. The qualitative component found perceived value of the 
intervention was high. Barriers were participant’s personal difficulties and cannabis use. Facilitators 
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were participants’ desire to change, free EC and social dynamics. Staff capacity to support the study 
was generally good. Carbon Monoxide (CO) validated sustained abstinence rates at 24 weeks were 
6.25% (3/48) in the EC arm vs. 0/32 (0%) in the UC arm (intention to treat). Almost all participants 
present at follow-up visits completed measures needed for input into an economic evaluation 
although information about staff time to support UC could not be gathered. The cost of providing the 




Clusters could not be fully randomised due to lack of centre readiness. The originally specified 
recruitment target was not achieved and recruitment was particularly difficult in residential centres. 




The study was associated with reasonable recruitment and retention rates and promising acceptability 
in the EC arm. Data required for full cost-effectiveness evaluation in the EC arm could be collected but 
some data was not available in the UC arm.  
 
Future work: Future research should focus on several key issues to help design optimal studies and 
interventions with this population, including: which types of centres the intervention works best in;  
how best to retain participants in the study;  how to help staff to deliver the intervention and how 
best to record staff treatment time given the demands on their time.   
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Plain English Summary  
Smoking rates are exceptionally high among adults experiencing homelessness. Supplying a free e-
cigarette (EC) starter kit at homeless centres may be one way to help smokers to quit. This was a small 
study which explored whether smokers visiting homeless centres would be willing to take part and if 
they would return to complete questionnaires 6 month later. We also wanted to find out what people 
thought worked or did not work well for them and whether we could collect information needed to 
assess cost-effectiveness and success in a larger trial. 
 
We recruited 80 smokers from 4 homeless centres: 48 received an EC and 32 people took part in usual 
care (UC). UC is defined as signposting to the local Stop Smoking Service (SSS) because this is what is 
most often available at these centres.  
 
Sixty people (75%) returned to provide follow-up information after 4 weeks; 50 people (63%) came 
back at 12 weeks; and 47 (59%) came back at 24 weeks. Interviews with participants and staff at the 
centres showed the study was useful and worthwhile. Although nobody who came back at 24 weeks 
managed to stop smoking in the UC group, in the EC group 11% (3/35) of those who came back at 24 
weeks had quit smoking. We were able to collect the information we needed to assess cost-
effectiveness of providing an EC. This was estimated to be £114.43 per person. We could not estimate 
costs of UC.  We found that enough people were interested in taking part that it would be worthwhile 
running a larger study but this would need to include more people, more centres and explore ways 
that we could make sure more people came back at 6 months  
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Scientific Summary  
At current times, smoking prevalence is at a historic low in the UK. Smoking prevalence rates have 
dropped across all socioeconomic-status groups but remain considerably higher in adults with difficult 
lives including those with poor mental health and substance use comorbidities.  Adults experiencing 
homelessness represent one group where prevalence rates, even at the minimum estimate, are four 
times higher than the national average. Tobacco related diseases are a leading cause of death amongst 
this group. However, smokers from this population are not well represented within health services 
including stop smoking services, despite a desire to quit which is no different to those who are not 
homeless. E-cigarettes (EC) are now the most popular quit method in England and there is increasing 
evidence for their efficacy within trials alongside behavioural support and effectiveness at a 
population level. The efficacy of EC for quitting or reducing smoking have not been tested within a 
homeless population. This feasibility study with embedded qualitative process evaluation was 
undertaken as a precursor to a main trial which would explore the efficacy of EC for smokers accessing 
homeless centres compared with usual care (UC).  
Seven key objectives were examined to inform a future trial. 1: Assess willingness of smokers to 
participate in the study to estimate recruitment rates and inform a future trial. 2: Assess participant 
retention in the intervention and control groups. 3: Examine the perceived value of the intervention, 
facilitators and barriers to engagement and influence of local context. 4: Assess service providers’ 
capacity to support the study and the type of information and training required. 5: Assess the potential 
efficacy of supplying free EC starter kits. 6: Explore the feasibility of collecting data on contacts with 
health care services within this population as an input to an economic evaluation in a full RCT. 7: 
Estimate the cost of providing the intervention and usual care. 
This was an 18-month mixed method study delivered across four homeless centres; two centres in the 
EC cluster, and 2 in the usual care cluster. A cluster design was adopted following the advice of our 
Public and Patient Involvement (PPI) and centre staff in order to reduce contamination and 
disharmony between participants allocated to different conditions. Recruitment took place between 
January and June 2019. Usual care (UC) participants received advice to quit and were signposted to 
the local Stop Smoking Service. EC intervention participants received a starter kit and 4-weeks supply 
of e-liquid, provided at weekly intervals. Follow-up assessments were conducted at 4, 12 and 24 
weeks. Outcome measures were the proportion of eligible individuals agreeing to take part and 
returning for follow-up, the proportion who still had and who were still using ECs at each follow-up, 
participants’ experience of the study, service providers ability to support the study, smoking cessation 
at each follow-up point. We also collected health care utilisation data in order to pilot the health 
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economics questionnaires and also recorded the resources used in the delivery of the study in order 
to estimate cost.   
Eighty of the 153 (52%) eligible participants invited were successfully recruited; 48 (56%) in the EC arm 
and 32 (50.5%) in the UC arm) and recruitment was most successful in day centres. Retention rates 
were 75%, 63% and 59% respectively at 4, 12 and 24 weeks and retention were higher in the EC vs UC 
arm (24-week retention = 73% vs. 38%). The difference between arms was largely due to poor 
retention rates at the Edinburgh site and there were higher levels of baseline co-morbidities (physical 
and mental illness and substance misuse) in the UC vs. EC arm. Of those who could be followed up, 
the CO validated sustained abstinence rate at 24 weeks was 3/35 (11%) for the EC arm and 0/12 (0%) 
for the UC arm. Assuming that all those with missing follow-up data were smoking (ITT), the 24-week 
sustained abstinence rate was 6.25% (3/48) in the EC arm vs. 0/32 (0%) in the UC arm. 
 
Qualitative interviews with a sub-sample of participants and staff showed perceived value of the EC 
intervention was high. Barriers to engagement were participants’ personal and psychological 
difficulties and cannabis use. Facilitators were participants’ desire to change, free EC and social 
dynamics. Staff capacity to support the study was generally good although some mentioned that they 
would like more support and guidance around how to approach potential participants about 
recruitment. Almost all participants who were present at follow-up visits completed data collection 
for healthcare service and health-related quality of life measure. However, whilst it was feasible to 
collect information relating to the cost of delivery in the EC arm  collecting data from staff about their 
contact time when delivering the intervention was not possible in the UC arm In total, the mean costs 
of the EC intervention, including training and delivery, were £114.42 (SD £22.89) based on data from 
43 participants in the EC arm. It was not possible to estimate costs for the UC arm. 
 
Reasonable study recruitment and retention rates with promising acceptability were observed. This is 
a hard-to-treat population but with careful consideration around the study design and further public 
involvement a future trial may be feasible.  
Funding: This study is funded by the National Institute for Health Research Public Health (project 
reference: 17/44/29). The views expressed are those of the author(s) and not necessarily those of the 
NIHR or the Department of Health and Social Care. The e-cigarettes were funded by the Centre for 
Addictive Behaviours Research, School of Applied Sciences, London South Bank University. 
 
Registration: The protocol was registered at the Research Registry: researchregistry4346; 
registration date: 21/08/2018 and ISRCTN14140672: registration date: 07/11/2018 
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Smoking prevalence rates have continued to decline in the UK, with fewer young people starting to 
smoke and greater numbers of people quitting1. Smoking has also continued to decline across all 
socio-economic status groups. However, those from the most disadvantaged groups, such as those 
presenting with multiple and severe mental illness and substance use comorbidities, present smoking 
prevalence rates which far exceed groups without2–5.  
 
Smoking is extremely common amongst adults experiencing homelessness, with prevalence rates 
ranging from 57- 82%4; this is up to four times higher than the UK national average (15.1%)1.  
 
Smoking is related to premature death and disease and quitting can have a substantial positive impact 
on reducing harm and increasing life years6. In smokers experiencing homelessness, tobacco related 
disease has been cited as the second single cause of premature death and the single largest cause of 
death in over 457. Smoking is particularly fatal within this population because of a higher incidence of 
respiratory infection and disease8. These conditions are likely to be exacerbated because of a general 
likelihood of engaging in practices which increase the risk of developing respiratory infections, for 
example, smoking discarded cigarettes and sharing cigarettes which act as a vessel for passing viral 
contaminants9,10. Poor respiratory health is also likely to be aggravated by smoking unfiltered and illicit 
tobacco, dragging harder on cigarettes and taking longer deeper puffs9. Beyond the health effects, 
smoking is also related to several social disadvantages; smokers experiencing homelessness are likely 
to engage in begging or ask strangers for cigarettes and are reported to spend up to a third of their 
income on tobacco and cigarettes11.  
 
Smokers experiencing homelessness have lives which mean that quitting smoking is not a high priority 
and is also often overlooked by those who support them12. There is also some evidence that health 
and social care professionals are concerned that cessation will exacerbate mental illness and that 
taking something away, when many of these adults have so little, will be unfair or cruel13. While these 
concerns are understandable, a survey we conducted in 2018 of 286 smokers accessing homeless 
services in England and Scotland showed that 75% smokers have some desire to quit smoking and 75% 
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have some history of quitting, however, quit attempts are often unsupported by behavioural support 
or licensed nicotine medication, and last less than 24 hours14.  
 
The UK has a clear goal of reducing the harms caused by tobacco smoking; central to this is the 
reduction of tobacco related health inequalities through improving cessation rates. At the current 
time however, smokers experiencing homelessness are not well represented within the SSS and 
cessation support is not mandatory within homeless centres. In the recent Tobacco Control Plan for 
England15, the Department of Health and Social Care (DHSC) expresses its commitment to evidence-
based innovations to support quitting and will seek to support smokers adopting the use of less 
harmful nicotine products such as EC. Nevertheless, smoking cessation within the context of 
homelessness is underexplored within the UK. Our recent systematic review of 53 studies showed that 
only two cross sectional studies had been conducted in the UK4 of which one was conducted by our 
group14. Trial evidence from the US shows that there is potential to support cessation in this group. 
For example, Okuyemi et al.16 measured the efficacy of motivational interviewing (MI) offered 
alongside licensed nicotine replacement therapies (NRT) compared to NRT alone. Using intention-to-
treat analysis, verified 7-day abstinence rates at week 26 were 9.3% for MI + NRT and 5.6% for NRT 
alone (P = 0.15). Prior to the work presented here, there were no smoking cessation intervention 
studies within the UK. In order to reduce the burden of smoking within this population, more evidence 
of the efficacy of interventions is clearly required.  
 
Our systematic review4 and PPI work (conducted in 2017, with 7 homeless centres, and 8 interviews 
from one major homeless charity, and scoping data from 100 participants) helped to shape the design 
of this study. We were told that the multiple competing needs in this group meant access to support 
needed to be made easy and appealing in order provide the best chance of engagement. Thus, it was 
decided that the feasibility study  should be embedded within centres that participants were already 
accessing. Our PPI work also suggested that EC may be particularly appealing to smokers experiencing 
homelessness because i) smokers in our scoping work were already experimenting with them, ii) they 
can be framed as a switch rather than a quit (which has connotations of loss) which has been 
highlighted as an issue of cessation, iii) they can be offered at a location already being visited without 
a prescription, thus reducing the burden of making further appointments and removing a clinical 
approach. Taken together the feedback was that EC offer a pragmatic harm reduction approach to 
smoking cessation, and this is especially important when delivering interventions within the third 
sector where substance harm reduction is already well established.  
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An individually randomised trial with allocation to one of two arms (EC vs. UC) was initially considered 
but our PPI feedback (from staff and clients at homeless centres) strongly advised against this due to 
potential problems with compliance, contamination and issues of disharmony, e.g. resentment 
towards staff delivering the intervention that one person had received an EC and another not. 
Contamination, harmony and protection of staff were important; therefore, our decision was to opt 
for a feasibility cluster trial.  
 
Here we present a pragmatic four-centre cluster feasibility study exploring the uptake and use of EC 
to smokers accessing homeless support services. The overall purpose of this research was to evaluate 
the feasibility of supplying free EC starter kits for smoking cessation to smokers experiencing 
homelessness at a place which they are already accessing. The UC arm received standard existing 
treatment: advice to quit, an adapted NHS Choices factsheet for smoking cessation and signposting to 
the local SSS which offers weekly behavioural support and choice of NRT or varenicline. The EC arm 
received a starter kit, 4-weeks supply of e-liquid and a fact sheet. 
 
Objectives  
To test the feasibility of future trial work, seven objectives were set. Table 1 presents the study 
objectives and associated outcome measures and whether the objective is specific to the cluster level 
or across levels.  
 
Table 1: Feasibility study objectives and outcome measures 
Objective  Outcome measure Measured at:  
O1. Assess willingness of 
smokers to participate in the 
feasibility study to estimate 
recruitment rates and inform 
a future trial. 
In both arms, we will record the 
number of smokers asked to take 
part and the number who consent.  
Across arms 
O2. Assess participant 
retention in the intervention 
and control groups. 
Record a) how many participants 
complete assessment measures in 
each arm at each time point b) how 
many participants still have, and 
Across arms  
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are still using, e-cigarettes in the 
intervention group. 
O3. Examine the perceived 
value of the intervention, 
facilitators and barriers to 
engagement and influence of 
local context. 
Qualitative interviews with 4-week 
completers and non-completers, 
quitters and smokers (N=24, 
approx. 6 per site) between weeks 
4 and 8 across both arms.  
Across arms  
O4. Assess service providers’ 
capacity to support the study 
and the type of information 
and training required. 
Qualitative interviews with 
keyworkers and front-line staff 
(N=12; approx. 3 per site) across 
both arms. 
Across arms  
O5. Assess the potential 
efficacy of supplying free EC 
starter kits 
Measure breath CO levels, self-
reported quit rates/cigarette 
consumption and HRQoL (using the 
EQ-5D-3L) at each follow-up time 
point. 
Across arms 
O6. Explore the feasibility of 
collecting data on contacts 
with health care services 
within this population as an 
input to an economic 
evaluation in a full RCT. 
Record participant utilisation of 
primary and secondary health care 
services using a self-report service-
use questionnaire at each time 
point. 
Across arms  
O7. Estimate the cost of 
providing the intervention and 
usual care. 
Record all resources used in the 
delivery including staff costs, e-
cigarettes and other costs incurred. 
Staff will complete a pro forma to 
record contact time, non-contact 
time and other resources used in 
delivery. 
Across arms  
HRQoL: Health-related quality of life. Carbon Monoxide: CO. 
Methods 
Trial design  
A four-centre cluster feasibility study with embedded qualitative process evaluation. A deviation from 
our protocol was made to the study  design owing to the availability of centres Centres were 
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counterbalanced in each condition but not randomised (see ‘cluster allocation’ below. However, 
participants joined after cluster allocation and allocation was concealed to participants until after the 
baseline assessment. Recruitment was within a discrete period starting from site initiation at each 
location (6-weeks).  
  
EC sites offered an EC starter kit at baseline assessment. EC arm is formed of two EC clusters.  
 
UC is defined as offering an adapted NHS Choices fact sheet for smoking cessation and signposting to 
the local SSS. UC arm is formed of two UC clusters. An illustration of the clusters is outlined in Figure 
1.  
Consent was taken at baseline by the research team. Follow up data at weeks 4-12 and 24 weeks was 





Participants were selected by homeless centre staff based on the inclusion criteria below. Further 
eligibility checking was performed at baseline by the researcher. Eligibility criteria did not differ 
between clusters.  
 
Inclusion criteria: Adult smokers (18 and over) accessing homeless support services on a regular basis 
and also known to staff. Self-reported daily smokers only with smoking status also confirmed by 
support staff. Smoking status was also biochemically verified by exhaled CO breath test at recruitment. 
To gain wider representation we did not exclude those who reported mental illness or substance 
dependence. 
 
Exclusion criteria: non-smokers, or those reporting using another smoking cessation aid at the current 
time, any one below the age 18 years, reporting pregnancy, or unable to consent e.g. currently 
























     
           Usual care       
  
 
      
   E-cigarette  
 
EC arm: Northampton (Centre 1), and London (Centre 4).  
UC arm: Edinburgh (Centre 2), and London (Centre 3).  
 
Description of settings:  
Centre 1 (EC cluster): This is a day centre (open Monday to Friday; 8.30am – 1pm) located within 
Northampton. Staff and volunteers, support workers, keyworkers, social workers and kitchen staff 
work to provide a range of facilities and programs to serve the practical, physical, and social needs of 
people experiencing or at risk of homelessness in the area. There is a breakfast and lunch service, 
training and employment skills programs, and an emergency night shelter (run separately by the local 
council) for use during periods of inclement weather. The kitchen and day centre are open on Saturday 
mornings for people who are sleeping rough or in emergency accommodation. 
 
Centre 2 (UC cluster): This is a day centre (open Monday to Friday; 9am – 1pm) located within the city 
of Edinburgh. It offers breakfast, lunch, shower and clothing facilities as well as spiritual support 
through chaplaincy and recreational facilities (TV, pool and day trips). Support staff provide crisis 
intervention advice and assistance with benefits, housing, accessing medical services for physical and 
mental health and social and life skills emotional support.  
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Centre 3 (UC cluster): operates three linked sites of supported accommodation in London for people 
at risk of homelessness. Each site accommodates clients whose needs fall within the parameters of 
the level of care it is able to provide.  
 
Site 1 has 21 bedsits in 3 adjoining three-and-a-half-storey houses with a shared garden and is staffed 
24 hours for people with greater complex needs.  
 
Site 2 has 12 bedsits for male residents who are semi-independent and benefit from support of regular 
check-ins, health support, and help with advocacy and paperwork. The office staff are available during 
Monday-Friday between 9-5.  
 
Site 3 has seven units in one four-storey building. The residents are both men and women who are 
living mostly independently, with the support workers providing advocacy, signposting to services, 
and on-site management. 
 
 
Centre 4 (EC cluster): Also located in London, it provides supported accommodation across four linked 
sites: Staff and volunteers include: keyworkers, complex needs workers, kitchen and maintenance 
staff.  
 
Site 1 is a 23-unit residential support service for men and women. Single accommodation units are set 
on two stories and overlook an enclosed communal garden. There is a multi-purpose meeting space 
in a small unit within the garden where staff run skills classes and social groups. Staff are on-site 24 
hours for management and security. Residents have a range of abilities and needs, with an aim to 
return to independent living. Staff aim to support people to with complex needs through semi-
independent living with keyworker support, advocacy, and daily check-ins.  
 
Site 2 is a 13-unit women’s only supported accommodation, offering support for women who have 
been or at risk of becoming homeless. The accommodation provides single occupancy 
accommodation. There is a shared garden with chickens and a shared communal lounge and kitchen, 
but no private meeting spaces. Keyworkers provide support sessions within usual 9-5 working hours.  
 
Site 3 is a short stay house and site 4 provides first-night accommodation only (to provide emergency 
accommodation intended for people who are newly homeless or acutely at risk of rough-sleeping). 
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The researchers routinely kept reflexive diaries to record observations and reflections about local 
contexts, as well as notes on psychological impact of working in new and sometimes unpredictable 
environments where people are reacting to multiple, chronic and/or acute stressors and complex 
needs. These research notes formed the basis of debriefing meetings and discussions within the 
research team, in part to be informative of ecological differences between sites as well as to 
systematise the physical and psychological safety of the researchers. 
 
Interventions 
Interventions were delivered at cluster level. Appendix 1 presents the CONSORT flow diagram, which 
provides a summary of the stages of the study by intervention.  
 
Pre-intervention staff training  
The research team provided four education and training sessions to staff in each centre, one to two 
weeks before recruitment started. The educational content followed National Centre for Smoking 
Cessation and Training (NCSCT) recommendations, to ensure centre staff had a basic knowledge of 
the issues which surround smoking and smoking cessation and to optimise the delivery of the EC and 
UC interventions. The training was developed and led by Dr Debbie Robson (King College, London) 
with support of the research team (LD, AT, SC, IU and AF); Table 2 presents an overview of the delivery 
of the staff education and training to 32 staff members across centres. However, not all staff were 
able to attend the education and training sessions. Also, new staff were employed in some centres 
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UC: Usual care. EC: e-cigarette. Duration refers to the total training time (excluding time to set up). 
Time for individual coaching was not monitored.  
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Education and training content for both intervention arms included the following:  
1. Prevalence and patterns of smoking among the wider population and people experiencing 
homelessness  
2. Health effects of smoking  
3. Benefit of smoking cessation  
4. Common misperceptions around smoking cessation within the context of other addictions 
and mental illness  
5. Why this study was important and why it was needed now  
6. How to complete the baseline and follow-up forms and what was expected from staff  
 
Additional EC training:  
Staff were expected to deliver the intervention and were therefore provided with information on the 
evidence base of EC use, effectiveness and safety among the wider and population and a rationale 
about why EC may be useful for this group. Also, within the training session, staff were provided with 
information about how to deliver correct advice about EC to participants and given a practical hands-
on demonstration relating to aspects of EC assembly, how to use the device, charge it, refill the tank, 
replace coils and battery safety.  Including the practical hands-on demonstration meant the EC 
intervention training took up to 45 minutes longer than the UC training.  
The research team in the EC arm provided additional coaching in preparation for each staff member’s 
first two keyworker sessions at baseline, and through shadowing and feedback at ongoing sessions. 
Ongoing informal training was provided, in the form of question and answer discussions with staff 
between keyworker sessions and before and after participants’ arrival.  
Additional UC training:  
As above, staff were asked to deliver the UC referral information, so staff were provided with detailed 
information on the role of SSS, current licensed medications available to smokers within their local 
SSS and evidence for their effectiveness. Staff were informed that at the time of training, licenced stop 
smoking medicines alongside behavioural support offered at the SSS was the most effective way of 
quitting smoking. Details of the centre’s local SSS and how to make a referral was also included in the 
training.  
EC Intervention  
All participants within the EC cluster (Centres 1 &4) received the same intervention.  
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Participants were provided with an unboxed Aspire PockeX kit starter kit comprising a tank-style 
refillable EC with a spare atomiser, charger and wall adapter plug. They were offered five bottles of 
10mL e-liquid, choosing from a combination of: a) nicotine strength e-liquid (two options: 12 & 
18mg/mL) and b) flavours (three options: tobacco, fruit, menthol). 12 and 18mg/mL nicotine strength 
e-liquids were chosen based on previous reports from our group and others of high nicotine 
dependency among smokers experiencing homelessness14. The EC brand and e-liquid were decided 
upon following our PPI work and advice from vapers. Vapers known to the research team who have 
engaged in other research suggested four of the top selling, easy to use ECs. Upon purchasing these, 
smokers from one London homeless centre tried the four different ECs and provided feedback on ease 
of use, nicotine hit and likeability. The Aspire PockeX was consistently rated as the easiest and most 
satisfying to use. The flavours were recommended by a vape retailer because these are the most 
popular, in terms of best-selling varieties.  
 
At this time the keyworker showed the participant how to use the device; this included, how to (re)fill 
the liquid in the tank, how to charge the device, how to inhale and what to expect when first using 
the device. Participants were also provided with the device instructions, which in response to our PPI 
feedback, had been retyped in to larger font and a ‘Tricks and Tips’ from experienced vapers help 
sheet.  Participants were given time to try the device, and experiment with the different flavours and 
nicotine strengths and were permitted to switch between flavours throughout the follow sessions 
(Appendix 2 presents the selection of e-liquid flavours and concentrations that were given out by 
keyworkers). The keyworker recorded the participants’ choices of e-liquid and timing of the keyworker 
session in CRF forms that were kept with the study equipment. 
 
Once per week in the three weeks that followed the baseline meeting, participants met centre staff 
to report any concerns and collect up to 5 10mL bottles of e-liquid and a new atomiser each week. 
Ideally, participants met the staff member whom they had met at the baseline session and who had 
attended the staff training; however, because of staff turnover and time demands this was not always 
feasible. Staff recorded data on e-liquid and troubleshooting in the CRF. With a larger number of 
participants attending follow-up appointments at Centre 1, staff adopted a drop-in ‘surgery’ where 
waiting participants also interacted with peer advice and support. 
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Usual care intervention  
All participants within the UC cluster (Centres 2 & 3) received the same assessment measures but 
usual care differed across the two centres within this cluster. 
At the end of the baseline assessment, and within the same session, participants were informed of 
their centre allocation. Participants were then referred to their keyworkers/other centre staff who 
advised them to consider quitting and provided the fact sheet and an adapted NHS Choices ‘help-to-
quit’ leaflet, this included information about the location and opening hours to SSS local to the centre. 
Paper copies of the help-to-quit leaflet (with SSS contact details) were available as posters/flyers at 
homeless centres in the UC condition/cluster. Centre staff were asked to follow up with participants 
once a week for four weeks to record whether they had made contact with the SSS and to remind 




All participants were asked after baseline CRF completion if they would be interested in taking part in 
the qualitative process evaluation. Individual interviews were conducted in a quiet, private space on 
homeless centre premises, between weeks four and eight of the trial. A semi-structured topic guide 
was used to ensure all relevant topics were covered and interviews were digitally recorded with 
participants’ consent. 
The participants’ guide covered: smoking history; awareness of local SSS; experiences of trial 
processes; expectations and experiences of vaping (EC arm); and experiences of signposting to SSS 
(UC arm).  
The staff topic guide covered: staff role and trial involvement; existing cessation support for clients; 
and views and experiences of the trial, processes, and the EC or UC interventions. Both guides covered: 
unintended consequences and recommendations for improvements.  
 
Incentives for retention  
The wider literature on smoking and homelessness has shown that it is common practice to offer a 
financial incentive to participants and that this improves retention4. Regardless of cluster, all 
participants were compensated with a £15 ‘Love2Shop’ gift card for completing assessments at 
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baseline, follow-up and the qualitative interview (totalling £75). Staff did not receive a gift card for 
taking part in the interviews. Participant payment was not contingent on quitting or cutting down and 
this was stressed to the individuals taking part.  
 
Outcome measures 
Table 1 presents the outcomes and associated measures, including the relation to each intervention 
arm.  
 
Baseline Measures (across clusters)  
 
• Demographic information and homeless status/history.  
• Cigarettes smoked per day, smoking history (e.g. length of smoking, previous number of quit 
attempts, support used) and past and current EC use.  
• Severity of tobacco dependence, measured by the Fagerström Test of Cigarette Dependence 
(Fagerström, 2012) and expired carbon monoxide (CO).   
• Motivation to stop smoking, measured by the Motivation to Stop Scale, a 7-level single-item 
instrument which incorporates intention, desire and belief in quitting smoking17,18.  
• Mental health status, measured using the 9-item Patient Health Questionnaire (PHQ9)19–21 for 
depression (total score ranging from 0 to 27 with a higher score indicating greater severity of 
depression) and the 7-item Generalised Anxiety Disorder (GAD7) questionnaire (total score 
ranging from 0 to 21 with a higher score indicating greater severity of anxiety)22,23.  
• Alcohol use, measured using the Alcohol Use Disorders Identification Test (AUDIT), a 10-item 
screening instrument developed by WHO to screen for alcohol problem. Scores range from 0-
40 with a score of >8 indicating harmful or hazardous drinking and >13 (females) or >15 (males) 
indicating alcohol dependence24.  
• Drug use measured using The Severity of Dependence Scale (SDS), a 5-item screening measure 
of psychological aspects of dependence yielding a total possible score ranging from 0 (no/low 
dependence) to 15 (high dependence)25,26. 
• General health care and service use measured using an adapted health care and social service 
utilisation questionnaire.  
• Health Related Quality of Life (HRQoL) measured using the EQ-5D-3L, a widely used measure 
which provides a single value for health status that can be used in the clinical and economic 
evaluation of an intervention27,28. 
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All questionnaires and measures have good psychometric properties and have been used in previous 
research with vulnerable populations.  
 
Follow-up Data Collection - UC 
At weeks 4, 12 and 24, the following information was collected:  
• Smoking information: self-reported smoking abstinence; number of cigarettes smoked in the 
last seven days (to measure 7-day point prevalence abstinence); number smoked per day (in 
order to calculate smoking reduction from baseline). 
• Exhaled CO breath test. 
• Engagement with the local SSS (appointments made and attended). 
• Use of EC and other tobacco/nicotine containing products. 
• General health care and service use; HRQoL; mental health status (GAD7, PHQ9). 
• Other drug use/dependence (AUDIT, SDS). 
• Direct and indirect staff contact time.  
 
Follow-up Data Collection) – EC 
As above and in addition: 
 
• 12 positive effects (e.g. throat hit, satisfaction, pleasant, craving reduction) and 21 
negative effects (e.g. mouth/throat irritation, nausea, headache, heartburn) of EC use, self-
reported using a Visual Analogue Scales (VAS) and summed to create a percentage 
score (higher score = higher positive or negative effect) as used in our previous studies29.  
• To further monitor risk and adverse effects (e.g. EC theft, exchanges, use for other 
substances), were assessed using unintended consequences checklist developed specifically 
for this trial. 
 
The research team collected all of the baseline and consent data and the 4, 12 and 24-week follow up 
data.  
Feasibility Study Outcome Measures  
1. To assess willingness to take part in the study, we recorded a) the number of people who were 
asked, b) the number eligible, and c) the number who consented, to take part.  
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2. Retention and engagement were measured by recording a) the proportion of participants who 
completed assessment measures in each arm at each time point, and b) the proportion of 
participants: i) still using EC in the intervention group and ii) who had visited the SSS in the UC group. 
3. To estimate the parameters for future trial at each follow-up point, we recorded: a) CO-
validated sustained abstinence (from 2-weeks post-quit date allowing up to 5 slips); b) CO-validated 
7-day point prevalence abstinence (i.e. no smoking at all in the last 7 days); and c) the proportion 
achieving 50% smoking reduction (calculated by subtracting CPD at follow-up from baseline).  
4. To explore the feasibility of collecting data on contact with health care services we recorded 
participant utilisation of primary and secondary health care services using a self-report questionnaire  
5. Staff contact time, non-contact time and other resources used in EC and UC delivery including 
staff costs, EC and other costs incurred was collected to provide an indicative cost of the intervention.  
 





As this was a feasibility study for a main trial, no formal power calculation based on detecting evidence 
for efficacy was conducted; the outcomes of study allowed us to calculate the required sample size 
(and an intra class correlation coefficient ([ICC]) for a possible future definitive cRCT.  
As per our published protocol30, a pragmatically chosen sample size (N=120, n=30 per centre, n = 60 
per cluster), was based on our pre-feasibility PPI work and also taking information from published 
works within similar samples. This information allowed us to identify evidence of feasibility, 
recruitment rates and any problems with the intervention or research methods. Our pre-feasibility 
scoping work suggested that the centres had daily contact with between 25 and 120 individuals, of 
whom 70-90% were likely to be smokers. Other studies in homeless populations have reported follow-
up rates ranging between 24% and 88% (depending on the location of visits, provision of incentives & 
use of prompts31. Therefore, we estimated that 50% of those who agree would drop out in the period 
between consenting to participate and the final follow-up at 24 weeks, leaving an estimated sample 
size at the final follow-up of 60.  
 
In relation to the qualitative process evaluation, we planned to interview a sub-group of 24 homeless 
smokers (approximately 6 per centre) and 12 staff members (approx. 3 from each centre). We also 
aimed to include continuing participants and those who did not complete their 4-week follow-up, as 
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well as those in the EC and UC arms. This sample size is adequate for collection of qualitative data 
necessary to assess objectives 3 and 4.  
 
Although there was no formal interim analysis or stopping guidelines, we did specify in our ‘project 
timetable and milestones’ that we would assess recruitment and 4-week retention at Centre 1 after 2 
months to determine whether to proceed with recruitment at centres 2, 3 and 4. 
 
Cluster Allocation 
The centres in Northampton (Centre 1) and Edinburgh (Centre 2) are both day centres, whilst the two 
London centres (Centre 3 & 4) are residential units. We planned to pair and match centres on 
accommodation provision; to wit, each one of the residential centres to be paired with one of the day 
centres. We would then randomly allocate the two London centres; one to the EC arm, the other to 
the control (UC) arm, with the accompanying pair (day centre) allocated to the other arm.  
However, when we were ready to begin recruitment, the centres in London had not confirmed their 
availability for training and study start date. Thus, centre allocation could not be randomised and 
therefore deviated from protocol: we started with the centre that was ready to start training and 
recruitment, which was the centre in Northampton. We allocated this first centre to the EC condition 
so that we could explore recruitment, 4-week retention and any unintended consequences associated 
with the intervention to determine whether to proceed with recruitment at centres 2, 3 and 4. Centre 
2 (Edinburgh) as the other day centre was therefore allocated to the UC condition. Centres 3 and 4 
(London) were allocated to the UC and EC arms respectively. Centre 3 was allocated to UC as it was 
geographically closer to the researcher who was still collecting follow-up data from centre 1 and we 
expected lower uptake in the UC condition.  
Thus the actual allocation of centres to each arm was non-random, a pragmatic decision based on 
centre readiness and staff/researcher availability though we balanced potential confounders and 
differences in environment by ensuring each cluster (EC and UC) contained one day centre and one 
residential unit.  
 
Allocation concealment mechanism  
As this represents feasibility work, a pragmatic approach was taken to the concealment of the 
intervention. Participants were told of the condition that they had been allocated to only after consent 
and baseline assessment; this was the same across the clusters. However, because of the nature of 
the conditions; namely that because those within the EC clusters were provided with a starter pack 
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and the social dynamics within centres (particularly day centres) were close-knit and interactive, the 
centre allocation was quickly revealed between participants and also to new participants.  
 
Contamination 
Contamination within the context of this design was defined as a participant receiving the intervention 
delivered by another participating centre, e.g., a participant in UC receiving a free EC starter pack from 








This is a feasibility for a trial in preparation for a future cRCT and analyses of effect are not appropriate. 
Analyses were conducted to evaluate the feasibility study outcomes (Table 1). Similarly, because this 
is a feasibility for a trial, subgroup analyses are not appropriate.  
 
Table 1 presents the objectives and associated outcome measure for each objective. Objectives 1, 2, 
5, 6, & 7 were measured quantitatively, and objectives 3 & 4 through the qualitative process 
evaluation. Each objective was measured across the whole sample, with the exception of objectives 5 
and 7 which relate to efficacy and cost effectiveness of the interventions. Table 3 presents the 
descriptive data for participant characteristics for the trial, Appendix 3 also presents the data for the 
subset of participants within the process evaluation.  
 
Baseline demographic data was summarised using frequencies and descriptive statistics and the arms 
(EC v UC) were compared using t-test/Mann Whitney U test or Fisher’s Exact test for continuous and 
categorical variables respectively.  EC effects are summarised descriptively. Changes in mental health 
status and substance use were explore over time and between arms using repeated measures ANOVA. 
 
Objectives 1 and 2: Participant willingness to take part and retention:  
Frequency information regarding the number of smokers who: i) were invited to take part; ii) were 
eligible to take part; iii) consented/completed the baseline assessment; iv) attended and 
completed each follow-up.  
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Objectives 3 & 4: To examine the perceived value of the intervention, facilitators and barriers to 
engagement and influence of local context, and assess service providers’ capacity to support the study 
and the type of information and training required:  
Interviews lasted between 16 and 65 minutes, were transcribed verbatim by professional transcribers, 
checked for accuracy and entered into NVivo 12 software32 to facilitate coding and analysis. Data were 
analysed using thematic analysis32. Separate coding frameworks for both participants and staff, with 
themes initially formed deductively, were developed using the main objectives and interview topics. 
The qualitative team (AF, IU, AT) conducted a first round of coding with AF, checking all coding for 
consistency. Through discussion, inductive themes were identified and agreed, leading to a second 
round of coding. Using an iterative approach, coded themes were then used as the categories for 
analysis. Data were carefully examined to identify the range and diversity of responses and themes 
and sub-themes were created and/or refined as appropriate. Findings were interpreted and discussed 
among the wider team. Quotations were selected to illustrate findings. The study arm for each 
participant (EC or UC, centre code (01-04) and whether the quote was from a trial participant or staff 
member are indicated alongside quotes.  
 
Objective 5: Assess the potential efficacy of supplying free EC starter kits 
The proportion of participants reporting sustained smoking abstinence, 7-day point prevalence 
abstinence (both CO verified), and a 50% reduction in smoking in each arm at each follow-up time 
point were recorded. These variables are presented with the denominator being the number who 
attended follow-up. Sustained abstinence is also presented and analysed using intention to treat 
analysis; that is, all those allocated are included in the analysis as belonging to the group to which 
they were originally allocated and those with missing outcome data were treated as smokers. The 
intraclass correlation coefficient was calculated by the Fleiss-Cuzick method.  
 
Objectives 6 and 7: To explore the feasibility of collecting data on contact with health care services 
within this sample as an input to an economic evaluation in a full cRCT and to estimate the cost of 
providing the intervention and usual care. 
The completeness of EQ-5D-3L and service use questionnaires was examined. We used the UK 
population tariff 33 to convert the results of EQ-5D-3L to utility value. QALYs were then calculated in 
each arm using the area under the curve plotted from baseline and follow-up points34. A set of national 
weighted average unit costs were extracted from secondary or published sources (see Appendix 4 and 
8). The quantities of services reported by participants were multiplied by the respective unit costs to 
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present a preliminary cost profile. We also present the costs of the programme, including training and 
delivery, the details of which were recorded by the research team. Results from the health economics 




Recruitment and 4-week follow-ups ran sequentially across the three sites in England with 12- and 24-
week follow-ups overlapping. Recruitment and data collection in Edinburgh ran in parallel with the 
second centre in England.  
 
The feasibility study was completed within the planned time frame. However, although we planned 
to recruit for 4-weeks at each centre, recruitment was extended to 6 weeks in the UC arm. This was a 
pragmatic decision taken with assistance from the Trial Steering Group, the research team and centre 
staff. Centre 1 saw high levels of interest in the study and extending the recruitment period to 6 weeks 
was not required. We did extend capacity within the 4-week window to recruit more participants who 
were interested in taking part, anticipating potentially lower uptake in smaller centres. Conversely, 
Centre 2 proved to be a particularly challenging for recruitment due to staff time and competing needs 
and resources. The research team had to adapt to the conditions of the centre, appointments had to 
be rescheduled and staff were not always available to assist. Centre 3 was quieter, overlapped with 
data follow-up at centre 1, and also residents had day time commitments which clashed with 
recruitment, again the research team needed to be flexible and therefore recruitment was continued 
over 6-weeks until we reached saturation.  
 
 
Sampling and recruitment for the qualitative process evaluation  
All those enrolled for the trial were asked at baseline about their willingness to take part in the process 
evaluation interviews and whether they were willing to be contacted at a later date to arrange an 
interview. After the intervention phase, those who had consented to be contacted were approached 
by a researcher by telephone, or in person at the homeless centre, and invited to take part. At centre 
1, staff identified participants whom they felt would be most willing to take part. Throughout the 
centres, staff who were supporting the participants and the project were also eligible to take part in 
an interview. Potential interviewees were provided with a participant information sheet and re-
contacted several days later. An interview date and time was arranged for interested participants. 
Written consent was obtained at the start of the interview. 
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Purposive sampling was utilised with a pre-determined target to recruit approximately six trial 
participants and three staff members at each of the four homeless centres. Trial participants were 
also to be sampled according to a) smoking status at week four of the trial, and b) whether they 
completed the week four follow-up.  
 
Centre 1 - EC 
Recruitment/baseline: 7th to 31st January 2019  
4-week follow-up: 4th to 28th February 2019  
12-follow-up: 1st to 25th April 2019 
24- follow-up: 24th June to 17th July 2019 
 
Centre 2 - UC  
Recruitment/baseline: 8th March until 25th April 2019  
4-week follow-up: 8th April and 17th May 2019  
12-follow-up: 4th June and 25th July 2019 
24- follow-up: 23rd August and 10th October 2019 
 
Centre 3 – UC 
Recruitment/baseline: 18th March to 2nd May 2019  
4-week follow-up: 18th April to 18th May 2019  
12-follow-up: 18th June to 18th July 2019 
24- follow-up: 10th September to 25th September 2019 
 
Centre 4 – EC  
 Recruitment/baseline: 13th May to 5th June 2019  
4-week follow-up: 10th June to 4th July 2019  
12-follow-up: 7th August to 28th August 2019 
24- follow-up: 28th October to 20th November 2019 
 
Process evaluation 
Interviews were conducted between February and July 2019 by one of a mixed gender team of three 
full time qualitative researchers experienced in interviewing vulnerable groups (AF, AT, IU). 
 





Baseline data is presented in Table 3: Participant Baseline Characteristics , below.  
The mean age of the sample was 42.66 years, 65% were male. Participants were primarily white 
(76.3%) and heterosexual (85%).  
Mental illness, health and substance use comorbidities  
Seventy-four percent of the sample self-reported a long-standing illness, 38.8% had been previously 
admitted to hospital due to mental illness, 55% scored 10 or over on the GAD7 indicating presence of 
Generalised Anxiety Disorder and 60% of participants scored 10 or over on the PHQ9 indicating the 
presence of major depression.  
 
In relation to alcohol use, 33.8% of participants had an AUDIT score over 8 suggesting that they were 
drinking at harmful or hazardous levels. SDS, were also high (5), indicating a high prevalence of 
substance dependence.  
 
Half the participants reported having previously spent time in prison. A significant proportion (38.8%) 
of the participants, women and men, reported being a victim of domestic violence.  
 
The arms also differed significantly on a number of baseline variables, namely GAD7, SDS, cannabis 
joints per day, time spent in prison, physical illness and motivation to quit with the UC arm scoring 
higher in all cases but lower motivation to quit (see Table 3). 
 
Education, employment and housing status 
37.6% were educated to A-level/Highers (or equivalent) or above. Employment status varied, 2.5% 
reported being in current paid employment and 97.5% reported recourse to benefits (social 
security/benefits). Just over half of the sample (60%) were currently housed in supported 
accommodation or in a hostel, 8.8% reported sleeping rough.  
Cigarette dependence and smoking behaviour  
The mean number of cigarettes smoked per day (including roll ups) was 20 (SD=15.33), this is equal to 
a pack per day in the UK. Mean expired CO breath level was 20.29 ppm (SD=10.04). The FTCD score 
was 5.51 (SD=2.47). In relation to smoking practices which increase the risk of respiratory infection, 
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55% reported that they shared cigarettes (24% reported doing this daily), 43% reported that they had 
smoked discarded cigarettes (6% reported doing this daily).  
 
Motivation to stop smoking (MTSS) varied considerably although, only 6% reported that they did not 
want to stop smoking, the large majority expressed a desire to quit smoking in the near future.  
 
Differences between the intervention arm  
The proportion of participants who had previously spent time in prison or who had a long-standing 
illness, disability or infirmity was significantly higher in UC compared to those assigned an EC. UC arm 
participant also scored higher on anxiety and substance dependence, smoked more cannabis joints 
per day and were less motivated to quit smoking. Given these differences and the differences between 
centres (see description of settings, p. 18), we conducted sensitivity analyses (One Way ANOVA with 
post-hoc tests for continuous variables and Fisher’s Exact Tests for categorical variables; not per-
protocol) to explore differences between the four centres on variables where there was a significant 
difference between arms. Cannabis smoking and substance dependence scores were significantly 
higher at the day centre in Edinburgh (centre 2; UC) compared to all other centres (all p’s<0.01 for 
cannabis smoking and all p’s<0.05 for SDS) which did not differ from each other. Similarly, anxiety 
(GAD7) scores were also highest at centre 2 and differed significantly from centre 1 (day centre, 
Northampton, EC) and 4 (residential centre, London, EC) (p<0.05) but not centre 3 (residential centre, 
London, UC) and centres 1, 3 and 4 did not differ from each other. Motivation to Stop Smoking (MTSS) 
was significantly higher at centre 1 compared with all other centres (p<0.01) which did not differ to 
each other. A higher proportion of participants from centre 2 had spent time in prison (73% vs 36%, 
50% and 56% respectively in centres 1, 3 and 4). The difference between centre 1 and 2 was 
statistically significant (p<0.01). A higher proportion of participants from centres 2 (91%) and 3 (90%) 
(both UC) reported a long standing illness compared to those at centres 1 (67%) and 4 (44%). 
Significant differences were observed between centres 2 and 4 and 3 and 4 (p<0.05).  
 
Table 3: Participant Baseline Characteristics 
 Total N=80 EC arm UC arm P 
value 
Age (in years): mean (SD) 42.66 (10.79) 42.75 (10.90) 42.53 (10.78) .93 
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 Male 52 (65) 29 (60) 23 (71.88) 
Employment status N (%) 
 Full time school or college  
 Paid employment/self-employed 
 Government training scheme 
 Unpaid or voluntary work 
 Waiting to work, already obtained 
 Looking for work/training scheme 
 Prevented by temporary sickness/injury 
 Permanently unable to work  




































Current sleeping situation (last 7 days): N (%)* 
 Sleeping rough on streets/park 
 Hostel or supported accommodation 
 Sleeping on somebody’s floor/sofa 
 Emergency accommodation (refuge, shelter) 
 B&B or temporary accommodation 


































Backgrounds: N (%)* 
 Spent time in prison 
 Spent time in secure/young offender unit 
 Spent time in local authority care 
 Spent time in the armed forces 
 Admitted to hospital due to mental illness 






























Highest level of education: N (%) 
 School (stopped prior to GCSE/standard grade 
 School (GCSE/Standard grade) 
 College (A-level/FE/Highers) 
 University (degree level) 
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Ethnicity: N (%) 
 White  
 Asian/Asian British  
 Black/Black British  

















Sexual Orientation: N (%) 
 Heterosexual or straight 
 Gay or lesbian 
 Bi-sexual 
 Prefer to self-define 
























Immigration Status: N (%) 
 UK National 































 Prefer to self-define 

















Number of cigarettes/day: mean (SD) 20.07 (15.33) 20.5 (16.78) 19.41 (13.07) .86 
Expired CO: mean (SD) 20.29 (10.04) 19.60 (9.58) 21.31 (10.77) .46 
Number of joints per day: mean (SD) 0.7 (1.69) 0.29 (1.13) 1.73 (2.69) .02 
FTCD: mean (SD) 5.51 (2.47) 5.24 (2.53) 6.13 (2.35) .12 
Age started smoking: mean (SD) 15.17 (5.47) 16.02 (6.30) 13.92 (3.72) .09 
Sharing cigarettes: N (%) 






















Smoke discarded cigarettes: N (%) 
 Not at all 
 Occasionally 
 Regularly 

















Ask strangers for cigarettes: N (%) 
 Not at all 
 Occasionally 
 Regularly  

















MTSS: N (%) 
 I don’t want to stop smoking 
 I think I should stop but don’t really want to 
 I want to stop but haven’t thought about 
when 
 I really want to stop but I don’t know when I 
will 
 I want to stop smoking and hope to soon 
 I really want to stop & intend to within 3 
months 































Importance of quitting at this attempt: N (%) 
 Desperately important 
 Very important 
 Quite important 

















Determination to quit at this attempt: N (%) 
 Extremely determined 
 Very determined 
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Self-rated chance of quitting  









GAD7: mean (SD) 11.22 (7.09) 9.87 (6.86) 13.33 (7.04) .04 
PHQ9: mean (SD) 12.93 (8.15) 12.46 (7.97) 13.67 (8.50) .53 
AUDIT: mean (SD) 9.22 (10.20) 9.50 (10.46) 8.80 (9.93) .77 
SDS: mean (SD) 5 (4.81) 3.49 (4.13) 7.44 (4.90) <.01 
*Participants could select more than one option. MTSS = Motivation to Stop Smoking Scale: GAD7 = 
Generalised Anxiety Disorder Questionnaire: PHQ9 = Patient Health Questionnaire; AUDIT = Alcohol 
Use Disorders Identification Test; SDS = Severity of Dependence Scale; T-tests/Mann Whitney U used 
for continuous variables. Fishers Exact Test used for categorical variables. 
 
 
Numbers analysed  
Appendix 1 presents the CONSORT flow diagram showing the numbers for each intervention arm. 
 
 
Objective 1: Assess willingness of smokers to participate in the feasibility study to estimate 
recruitment rates and inform a future trial. 
Outcome: Record the number of smokers asked to take part, and the number who consent. 
 
Across the four centres, 177 participants were initially invited to take part. Of these, 24 were not 
eligible (16 in the EC arm and 8 in the UC arm). Of the remaining 153 eligible individuals (90 in the EC 
arm and 63 in the UC arm), 80 consented to take part in the study; 48 (56%) in the EC arm and 32 
(50.5%) in the UC arm. Although we did not reach the recruitment goal of 120 that we set ourselves 
(based on our preliminary scoping work), we did recruit these 80 participants within the originally 
specified five-month period. Recruitment also differed across centres; the two-day centres were most 
successful in terms of recruitment (39 consented at centre 1, 22 at centre 2), together accounting for 
77.5% of the total sample and there was a waiting list of participants who could not be recruited at 
centre 1 as the researcher had to move on to the next centre. The residential units had fewer eligible 
individuals, including fewer smokers, and potential participants were less available due to work or 
other appointments and less interested in the study. Also, (see discussion for more information), there 
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was less opportunity to recruit within the residential centres because of centre space and room 
availability and issues around disturbing residents.  
 
Summary learning points for a future trial 
Ensure sufficient researchers are employed on the project to deal with recruitment and limit sites to 
day centres only. 
 
 
Objective 2: Assess participant retention in the intervention and control groups. 
Outcome: Record a) how many participants complete assessment measures in each arm at each 
time point, b) how many participants are still using e-cigarettes in the intervention group.  
 
The CONSORT flow diagram presents the participant numbers at recruitment, and follow-up data by 
intervention (Appendix 1). Within the EC cluster, retention rates were 81%, 69% and 73% at 4, 12 and 
24 weeks respectively. Within the UC cluster retention rates were 66%, 53% and 38% respectively at 
4, 12 and 24 weeks.  
 
There was a lower rate of attendance within the UC intervention at the 12 and 24-week follow-up. 
The most common reason for not following up was that participants were no longer attending the 
services; although exact reasons were not formally documented by the research team, these reasons 
were highlighted informally via conversations with centre staff.  
 
This difference in retention between arms did not appear to be due to the UC condition per se but 
rather, to baseline differences which might influence ability to attend follow ups. The UC arm was 
associated with a higher incidence of criminal background, illness, disability, substance abuse, anxiety, 
and lower motivation to quit. (see Table 3). This was particularly the case for centre 2 (day centre in 
Edinburgh; see above) which was also associated with a far lower 24-week retention rate (26%) than 
centre 3 (residential centre in London; 67%).  
 
We asked all participants in the EC intervention if they were still in possession of the EC that we 
provided (although they did not have to present it at the appointment), and whether they were still 
using the EC since the last appointment. Assuming that all those who did not attend follow-up sessions 
did not still have, or were not still using, the EC, at 24 weeks 46% (22/48) still had the EC that we 
provided and 56% (27/48) were still using.  Table 4 presents the data based on the number of 
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participants who attended and answered the question at each follow-up. The greatest fall in use was 
between the 12 and 24-week follow-up, however 63% of those asked self-reported that they were still 
in possession of the device. Similarly, in relation to use, the greatest fall was between 12 and 24-week 
follow-up, however of those in attendance at 24-weeks, 79% reported that they were still using an EC, 
either the device that was provided at baseline or a different one.  
 
Table 4: Data for possession of and use of the EC provided at baseline for participants assigned to 
the EC clusters. NB: % is from those who attended follow-up only.   
 
    
EC Intervention  4-week follow-up  12-week follow-up 24-week follow-up  
Still have the EC? 
Yes 
  
33 (85%)  
  
28 (82%)  
  
22 (63%)  
No   
6 (15%)  
  
6 (18%)  
  
13 (37%)  
Still using an EC?    
Yes   
37 (95%)  
  
30 (91%)  
  
27 (79%)  
No    
2 (5%)  
  
3 (9%)  
  
7 (21%)  
UC: Usual care. EC: E-cigarette. Follow up times are scheduled from the baseline appointment.  
 
Summary learning points for a future trial 
Larger numbers, more clusters and official randomisation should reduce baseline differences between 
groups. Randomisation with stratification by region should also ensure that variables that predict drop 
out are equally distributed between groups thus reducing the difference in retention across arms. In 
the event of a future trial, it would be important to consider ways in which retention could be 
maximised including other ways of maintaining more regular contact with participants, e.g. increasing 
text and verbal contact between appointments 31. 
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Objective 3: Examine the perceived value of the intervention, facilitators and barriers to 
engagement and influence of local context. 
Outcome: Qualitative interviews with 4-week completers and non-completers, quitters and smokers 
(N=24, approx. 6 per site) between weeks 4 and 8 across both arms. 
This section presents the findings of 22 in-depth qualitative interviews with a sub-sample of study  
participants. Given difficulty in contacting most of those participants who had not completed their 4-
week follow-up, and with the majority of study participants smoking at week 4, it was not possible to 
conduct interviews with a good range of completers and non-completers, quitters and smokers as 
intended. However, there is a good spread of qualitative participants across the four homeless centres 
and both study arms (see Appendix 3 for the qualitative sample characteristics). Nineteen 
interviewees (86.4) had completed their week 4 follow-up and three (13.6) had not completed this 
follow-up. At the week 4 follow-up, 18 of the 22 interview participants (81.8%) were smoking, 1 was 
abstinent and 3 did not provide smoking information.  
 
 
We explored participants’ experiences of the study in line with research objective three. The findings 
present six topic summary themes: barriers and facilitators to study and intervention engagement; 
experiences of the EC intervention; experiences of UC; perceptions of study processes; unintended 
consequences; and perceived value. Local differences, where they exist, are highlighted in the text. 
The section ends with a summary of key learning points for a future trial. 
 
Barriers to study and intervention engagement 
Participants’ personal barriers 
Interview narratives highlighted the psychological and emotional vulnerability of many of our 
participants. Some explained that their mental state, attention difficulties, anxiety around social 
interaction, and difficulties with appointments, made engaging in treatment programmes challenging.  
 
“It is partly my mental health… I do panic about talking to people… It’s very hard sometimes, 
just to sit and explain yourself.” (Participant16, C03, UC) 
 
Several displayed mistrust in authorities and research. 
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“I thought ‘oh this definitely a government initiative they’re going to run a test on the 
homeless… maybe they’ve got a dodgy batch of [e-liquid] and they just want to see if it takes 
anyone out before they put them up for sale.’” (Participant02, C01, EC) 
 
While some reported being comfortable providing personal data as part of the study, this was a major 
concern for others, with particular anxiety around whether data would be shared, “if I thought my 
information was being shared, then I wouldn’t take part” (Participant11, C02, UC). 
 
Participants also lacked confidence in their ability to stop smoking and many reported their ideal 
outcome would be to cut down first, rather than stop straightaway, “if you can cut down, then you 
can go that further field” (Participant09 C02, UC). This was due to their reported reliance on smoking 
to deal with stress, isolation or boredom. Traditional stop smoking approaches, particularly NRT which 
was reported to have interacted unpleasantly with substance use or mental health in previous quit 
attempts, were unappealing for participants. This presented a significant barrier to engagement with 
local SSS for those in the UC arm.  
 
Cannabis smoking 
For participants regularly smoking cannabis mixed with tobacco, most reported wanting to reduce or 
stop their cannabis consumption, although this presented concerns and was highlighted as especially 
difficult given the associated pleasure, “I feel relaxed [smoking cannabis when] I’ve been wound up all 
day” (Participant11, C02, UC). Some noted how cannabis use had drawn them back to smoking in 
previous quit attempts.  
 
“I’ve quit smoking a couple of times and the thing that always brought me back was smoking 
weed with the tobacco.” (Participant04, C01, EC)  
 
Two participants, previously dependant on heroin, described reliance on cannabis as a protective 
factor in abstaining from other substances.  
 
 “I’m an ex-addict, I used to inject heroin etcetera, now I stopped all that and started smoking 
cannabis and that stopped me taking any other drug.” (Participant13, C02, UC) 
 
Participants experiencing mental health distress described that cannabis helped them to cope and 
were anxious stopping cannabis use would exacerbate their symptoms. 
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“I suffer from a lot of anxiety and depression, so it’s just heightened it. It made it worse, trying 
to stop.” (Participant11, C02, UC) 
 
Facilitators to study and intervention engagement 
Opportunity: right time and place 
All our interviewees reported desire to stop or reduce their smoking, expressing concerns about 
finances or health. Whilst most had tried to quit previously, negative experiences with NRT and 
mainstream routes of support (e.g. GP appointments) meant these approaches were unattractive. 
This made opting into an incentivised, on-site smoking treatment programme appealing. Many 
illustrated their receptivity to engaging with support at a place they already attended. Bringing 
smoking cessation aids and services to participants in their own environments was therefore a key 
facilitator for engagement. 
 
“I just thought if you were coming here and Tuesday is my day off, I’d definitely benefit by 
taking part… So why not?” (Participant15, C03, UC) 
 
 “So I’m glad that this has come along because I don’t think, if this hadn’t have happened, I 
would have bothered to give up. I had no plans of giving up, until that day, none.” (Participant 
19, C04, EC) 
 
Free e-cigarette starter kit and gift cards 
The incentive of receiving a free EC starter kit and/or Love2Shop follow-up gift cards played important 
roles in study engagement. While the gift cards received for attending follow-up appointments were 
valued by all participants, they were especially important for facilitating study recruitment for the UC 
group. 
 
“My main incentive – I can’t tell lies – is the £15 voucher aye. Why not? If you can come to the 
centre and make fifteen pounds, well then that is fine. Happy days.” (Participant11, C02, UC) 
 
In the EC arm, the offer of a starter kit capitalised on participants’ desire to quit and perceived lack of 
existing cessation options. Despite some participants’ lack of initial enthusiasm for vaping, participants 
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said it prevailed as worth trying, given the availability and offer of device and e-liquid, especially at a 
time of financial hardship. 
 
“[I] didn’t have to go out and buy it you see, you know, ‘here it is, just try it.’” (Participant07, 
C01, EC) 
 
“…the thought of maybe it might work and there’s nothing to be lost, there’s only something 
to be gained, you don’t have to pay for the device…” (Participant02, C01, EC) 
 
Providing free starter kits also overcame start-up cost barriers for those who had expressed previous 
interest in vaping. 
 
“I have wanted to do it before but thought it was going to be really costly to start up. I haven’t 
got a spare 30 quid to lay down, ever. (Participant19, C04, EC) 
 
Social context 
Social dynamics facilitated EC intervention engagement. Some participants described becoming 
strong study and vaping advocates. EC intervention buy-in, particularly from individuals with social 
status amongst peers, helped raise awareness and interest. Word-of-mouth communication quickly 
relayed vaping benefits to potential participants.  
 
“Everyone I see who smokes I tell them you’ve got to try it, and I really try and talk them into 
it. but I’m worried I’m becoming one of those [laughs] people that gives up smoking and just 
like is a pest. But I want to pester them because it's - I know it’s good.” (Particioant19, C04, 
EC) 
 
“…now four or five key people have done it and no one, there was no ‘oh are you vaping?’” 
(Participant02, C01, EC) 
 
Positive peer influence was especially prevalent at the day drop-in centre (Centre 1), with high 
demand for the intervention and the creation of a vaping community, characterised by peer advice on 
equipment and technique, and social vaping norms.  
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“I’ll go out, still socially… six or seven of us are vaping away… there’s no stigma attached to it 
anymore. You can just vape happily.” (Participant02, C01, EC) 
 
“… they encourage you to stop smoking, you encourage them. So it’s a bit of like support in a 
way. Moral support to try and cut down.” (Participant03, C1, EC) 
 
A vaping community was not as evident in the residential centre (Centre 4). Generally, in these 
residential units, the service users we met tended not to mix as much and reported more solitary 
activity, often staying in their rooms, “I don’t [notice others vaping] …I don’t pay any attention to them. 
I just come in and go out” (Participant21, C04, EC).  
 
 
Participants’ experiences of the e-cigarette intervention 
Participants in the EC arm provided detailed descriptions of their initial expectations, the information 
and instructions they received, the EC and e-liquids, and their experiences with vaping. 
 
Initial expectations 
Most participants had not tried vaping before, reporting little knowledge about EC. Many described 
their initial scepticism and low expectation that EC would help them to reduce or stop smoking. It was 
common for participants to think the intervention would not be suited to them. For others, 
engagement in the study meant going against their negative view on vaping, “I was anti-vape” 
(Participant02, C01, EC). 
 
“I did not think for a minute it would fit for me, and work with me at all. I had no hope... hugely 
low expectations…. I didn’t give myself a hope in hell.” (Participant05, C01, EC) 
 
E-cigarette information and instructions 
Most participants reported satisfaction with the information provided. Instructions were considered 
thorough and participants particularly valued the practical demonstration, which included advice on 
device set-up, maintenance, and use. Some said the practical help leaflets were useful to refer back 
to.  
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“They basically showed me how to use the vape and how to change the liquid… how to charge 
it… change my coil… what to do when I need to clean the vape out. So it was just a really big 
help because I didn’t really understand anything about vaping and vape pens before.” 
(Participant03, C01, EC) 
 
E-cigarette device 
Perceptions on the device were mixed. Some found it easy to use and liked its compact size, light 
weight and long-lasting battery. While there were several reports of batteries overheating, this issue 
was a suspected manufacturer fault. Others reported problems with durability, reporting that the 
device broke easily when dropped (a common occurrence), resulting in cracks and leaking e-liquid. 
 
“I mean I’ve dropped mine several times… I’ve sort of repaired it… it’s still leaking juice.” 
(Participant02, C01, EC) 
 
With no money readily available to replace devices or replacement parts, some had used tape to repair 
their devices. One highlighted the importance accessible and affordable replacement parts. 
 
“If you are going to use a vape on a study with vulnerable and homeless people, I would 
suggest you pick a vape that the parts are more accessible. Because, most of these things you 
have to go online to get them. And most of these people don’t have a bank account, let alone 
be able to go online.” (Participant01, C01, EC)  
 
E-liquid 
Finding a preferred e-liquid was important for continued use and participants had differing 
preferences. Perceptions on the e-liquid provided were generally positive. Many interviewees said 
they were satisfied with the variety of flavours, amount, and nicotine content. Experimentation was 
important for participants to find what suited them best. The flavour options were not liked by all 
however, and several suggested the study should provide a greater variety. Some described mixing 
flavours, exchanging flavours with others, and purchasing different flavours. 
  
“I think [the variety] covered all bases… I was telling everyone three quarters blueberry or half 
blueberry and half polar bear and seems to have gone down rather well.” (Participant02, C01, 
EC) 
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Some also commented that the available strengths were too high leading to initial adverse effects 
such as coughing or feeling sick which could put them off continued use.  
 
 “I shouldn’t have started on 18[mg] straight away... I think I went full out too strong…I didn’t 
give myself a chance. (Participant06, C01, EC) 
 
“… the 12[mg]s and 18[mg]s are very high. A lot of people get head rushes and things… I can 
hit it about twice before nearly passing out. I have to mix mine down.” (Participant04, C01, EC) 
 
Vaping experience 
Many interviewees noted their vaping frequency increased over time, with the reported realisation 
that vaping was helping with smoking reduction and more useful than NRT. Many were pleasantly 
surprised with these changes and intended to continue. 
 
It surprised me… I know 65% [smoking reduction] isn’t massive but I’ve been smoking 30 years. 
It’s a dramatic amount in the short space of time...” (Participant01, C01, EC) 
 
“Well at first… I thought maybe it’s just going to be a couple of days thing and then just put it 
on the side but no I use it every single day…it’s helped.” (Participant18, C04, EC) 
 
For some, vaping easily fitted in with existing routines and habits; it was easy to vape and more 
convenient than rolling a cigarette, especially when outdoors. One noted that vaping helped them to 
relax. Others found it more difficult to replace certain cigarettes with vaping, i.e. the first one in the 
morning or after dinner, and some described quickly choosing to smoke if their EC was unavailable or 
they were experiencing stress.  
 
“I probably smoke about 35% cigarettes and 65% vape… It changed for a little bit where I was 
doing about 50/50, but I was having a well stressful time… if I have a stressful day like I know 
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Participants’ usual care experiences 
There was little evidence of engagement with UC among our interviewees. While some said they 
appreciated the information provided in the help-quit leaflet, many acknowledged they hadn’t looked 
at it since the baseline appointment, “I’m sorry to say that I didn’t actually read through it” 
(Participant12, C02, UC).  
 
Only three of our interviewees made contact with local cessation support. When accessing support, 
participants emphasised that making contact with, or contact being facilitated by, someone they trust, 
was important. At Centre 2, participants with a methadone prescription reported good relations with 
the local pharmacist. While one participant obtained a nicotine inhalator this way, another did not 
obtain support as he was reluctant to speak with anyone else. 
 
INT: Have you managed to go to the pharmacy to get some advice on reducing your smoking? 
Resp: No because every time I go [pharmacist] is not there. 
Int: Okay. But they must have someone else who can do it? 
Resp: Aye but I get on well with [pharmacist] so I would rather talk to people that I know. 
(Participant13, C02, UC) 
 
At Centre 3, two of our interviewees attended the local SSS accompanied by their keyworker. Without 
this keyworker support, one participant noted, “I wouldn’t have gone on my own” (Participant15, C03, 
UC). Participants who had tried the UC approach were ambivalent about their experiences. The 
participant who used an inhalator complained of a sore head and nausea, had not found the nicotine 
delivery satisfying, and had not returned for further advice or support. At Centre 3, participants 
received a combination of patches and lozenges, however, they were critical of the advice provided 
and lack of availability of appropriate products. 
 
 “…they didn’t have the appropriate strength to my taste and they gave me a weaker one. But 
I’ve tried it maybe four or five days…. I didn’t quit smoking completely, but I reduced it like 
notably.” (Participant15, C03, UC) 
 
One UC interviewees reported greater success by combing NRT with an EC. It was common for UC 
participants to be interested in EC or to have purchased and used one during the study. Cross-
contamination was a feature of the study, as one participant explained: 
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“[Vaping] is helping me – buying my own one… [Researcher] told me that the other places 
were doing that. I thought ‘well, I’ll try my own one.’ (Participant10, C02, UC) 
 
 
Perceptions of study processes 
Understanding of the study 
Most of our interviewees reported awareness of which study arm they were allocated to prior to the 
baseline meeting. Some also noted a lack of detailed initial information about the study and its aims. 
This ties in with staff reports of how they communicated the study (see Objective 4). There were two 
notable exceptions where EC arm participants likened the baseline assessment to a test, where they 
perceived the offer of an EC would be “based on the answers” (Participant03, C01, EC).  
 
Pragmatic cluster design 
Participants’ accounts gave some indication of the appropriateness of the pragmatic cluster study 
design. In Centre 1 some participants perceived resentment from those not able to be recruited 
because the sample target had been reached, as they observed others receiving a free EC. This, 
combined with interviewees saying they would have felt “scorned” (Participant02, C01, EC) or “like I’d 
just wasted my time” (Participant21, C04, EC) if they had not been allocated an EC after completing 
the baseline questionnaires, suggests disharmony should both study arms have operated within one 
centre. 
 
Case report form (CRF) 
Some of our interviewees reported issues with the length of the baseline CRF, describing how sitting 
through a long appointment was difficult, “it’s not as easy for me to just sit, I fidget a lot” 
(Participant03, C01, EC). Others described questions alluding to substance use and mental health 
appeared misplaced within a smoking study, “why do you want to know about drug history or 
drinking?” (Participant18, C04, EC). Some noted emotional difficulty in responding to more sensitive 
questions. 
 
“It was difficult… it just brings back memories of things that – I tried to commit suicide three 
times… it did stress me a bit, but [researcher] was a nice man and he got me through it and 
we sat and sorted it out.” (Participant16, C03, UC) 
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Follow-up appointments 
While some interviewees reported no difficulty in attending weekly or the 4-week follow-up 
appointment, this was problematic for some, who attributed missed appointments to issues such as 
other commitments, difficulty remembering, hospital admission and being distracted by other life 
events such as those requiring police involvement. Having no credit on their mobile phone to 
rearrange, having their phone stolen, and sleep patterns were reasons given for non-completion by 




Use of e-cigarettes to vape other substances  
There was minimal evidence from our interview participants that the EC provided through the study 
was used to consume other substances. Only one interviewee said they had vaped cannabis e-liquid, 
which they had made, though they reported using this in a device previously purchased, not 
obtained through the study. 
 
It was, however, common for interviewees across both arms to report anecdotes of other people, not 
connected to the study, vaping cannabis e-liquid, “…yeah, people smoke weed in it...” (Participant01, 
C01, EC), CBD oil or THC: “…of course I’ve heard about it because I’m in [that] lifestyle…” (Participant09, 
C02, UC). Additionally, one participant at a UC centre, where no EC had been provided as part of the 
study, reported to have heard of somebody who had “cooked up heroin and put it in.” (Participant11, 
C02, UC). In response to interviewers’ enquiries, some participants with a history of drug use 
speculated on the possibility of using EC to vape other substances. 
 
“[I] suppose you could put heroin in an e-cigarette and it would do something. Not so with 
crack or coke. Don’t think there are many drugs you can put in there. Liquid ones, yes.” 
(Participant05, C01, EC) 
 
“There’s a definite similarity to smoking crack in its method and the sucking in… Yes the 
thought did pop into my head…” (Participant19, C04, EC)  
 
Love2Shop Gift cards 
None of our participant interviews provided evidence that gift cards received for attending follow-up 
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appointments had been traded for other substances or cash (although there were a small number of 
informal reports of this occurring from trial participants who did not take part in a qualitative 
interview.) Rather, the qualitative data highlighted that in most cases participants had used their gift 
card to buy essentials, most commonly food “I really need[ed] some food in. I had nothing. I was 
probably eating about twice a week at that point.” (Participant05, C01, EC). Some described the gift 
card as an opportunity to save up or buy something for a family member: “I can get my child school 
shoes now.” (Participant10, C02, UC). One interviewee said they had purchased alcohol with the gift 
card.  
 
Perceived value of the study and intervention 
All participants in the EC arm placed great value on the intervention and the opportunity to try vaping. 
Even though most had not made a complete switch from smoking to vaping, they described a strong 
belief in EC as a quitting aid, and valued their increased vaping and tobacco harm reduction 
knowledge. Many described feeling healthier and better about themselves since starting vaping. 
 
“I look in the mirror sometimes and see that I’m progressing, I feel a bit healthier. I’m not 
always having a cigarette.” (Participant03, C01, EC) 
 
“I feel very proud of myself for the first time in ages… and I’m glad that it’s had a healthy 
impact on my life…” (Participant19, C04, EC) 
 
“It does give you confidence… it’s made me think, ‘I can do something.’ Cos my confidence has 
been knocked a lot. It’s good.” (Participant05, C01, EC) 
 
Some believed the EC intervention could be wide reaching in its ability to help disadvantaged smokers, 
saying it could “help a lot of people” (Participant04, C01, EC), and “potentially save lives” 
(Participant02, C01, EC). 
 
“You’re giving people a chance because you’re giving them the equipment so, you know, 
they’re halfway there and then it’s up to you… that’s a good thing. People, like myself, that 
would have never thought of buying one.” (Participant05, C01, EC) 
 
Among the UC arm, some participants said they valued how the study made them consider their 
smoking and appreciated the information on where to access support, “…even just participating, just 
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even the thought that there is help out there to stop smoking is good enough” (Participant08, C02, 
UC). Most, however, believed EC would have been a more useful and effective approach.  
 
“It could have been useful to have been in the half of the study that had electronic cigarettes 
given to them.” (Participant14, C03, UC) 
 
Overall though, UC participants said they were pleased to have taken part. Across both arms 
participants valued how the study had enabled them to have their “voice heard” (Participant17, C03, 
UC) in relation to smoking. Some said they liked the thought that the study findings may help other 
homeless smokers in the future. 
 
“I’ve enjoyed it. It makes me feel important to be part of something that is important.” 




Summary learning points for a future trial 
 
Participants’ anxieties presented a significant barrier to study engagement. A sensitive and flexible 
research approach, characterised by participant/researcher trust can help to engage participants.  
 
While cannabis smoking is a barrier to smoking cessation more generally, a future trial would need to 
consider how best to manage and monitor cannabis use so study objectives are not undermined. 
 
Bringing smoking cessation aids and services to participants in their own environments was a key 
facilitator for engagement. Gift cards also incentivised participants to engage. 
 
Despite low expectations, participants were willing to engage with the EC intervention. Clear, practical 
instructions, a durable device with easily accessible parts, and the option of a lower strength nicotine 
e-liquid may help facilitate use.   
 
UC support was less attractive for participants. Previous negative experiences with NRT and anxieties 
about engaging with others were barriers to engagement. 
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Participants’ accounts suggest a cluster design is appropriate in homeless settings. Participants may 
have benefitted from clearer information on the study at the recruitment stage and a shorter CRF. A 
future study should carefully consider the questions included in the CRF to minimise the burden on 
participants and reduce potential areas of sensitivity. 
 
There was minimal evidence of unintended consequences, i.e. use of the EC provided to vape other 
substances or trading of gift cards, however a future study should continue to monitor this closely. 
However, device breakages were reported (see Harms below).  
 
Perceived value of the study and intervention was high among all participants. Participants’ desire to 
change their smoking behaviour and willingness to engage in the study presents a significant 
opportunity to engage homeless smokers in smoking discussions and treatment programmes.  
 
Local context had implications for the study on two issues. First, social dynamics at the busy drop-in 
centre facilitated intervention engagement and vaping social norms. Future EC interventions might 
therefore benefit from capitalising on peer influence to create a supportive vaping community. 
Second, centre links and relationships, i.e. with keyworkers or the local pharmacy were a key feature 
of whether participants in the UC arm engaged with support. Studies should consider the impact of 
these relationships on UC uptake.  
 
 
Objective 4: Assess service providers’ capacity to support the study and the type of information and 
training required. 
Outcome measure: Qualitative interviews with keyworkers and front-line staff (N=12; approx. 3 per 
site) across both arms. 
 
This section presents the findings of 12 in-depth qualitative interviews with keyworker and support 
staff involved in facilitating and supporting the study. This included assisting with recruitment and 
appointments, setting EC arm participants up with the device, for example showing them how to use 
the device and helping them choose an e-liquid, providing EC arm participants with weekly EC support 
and further e-liquid, and providing UC arm participants with brief advice to quit and signposting 
information for the local SSS.  The sample is spread across the four centres (see Appendix 3). We 
explored their experiences of the study in line with research objective 4. The findings present five key 
issues: staff assumptions; staff training; communicating the study; staff capacity to support the study; 
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and perceived value of the study. The section ends with a summary of key learning points for a future 
trial.  
 
Staff assumptions about smokers experiencing homelessness 
Most staff, across centres and study arms, perceived that stopping smoking was not a concern or 
priority for clients given other issues including mental health, substance use and chaotic lifestyles, 
“[smoking is] the less of all the evils” (Staff01, C01, EC). Other support needs were prioritised as staff 
believed smoking provided clients with comfort and enjoyment. These assumptions underpinned the 
lack of discussion about smoking between staff and clients, “it’s not something I would really discuss 
with them” (Staff07, C02, UC). Staff had few links to local SSS, little knowledge on smoking cessation 
and few established processes to support clients. 
 
“They have bigger things on their plates to deal with. I’m not going to try take away the one 
thing that they might enjoy. I’m already working with bigger challenges than that.” (Staff12, 
C04, EC)  
 
Prior assumptions meant some staff made judgements about which clients, if any, would engage in 
the study, “I thought no one would be interested” (Staff09, C03, UC). Other staff expected EC arm 
participants to sell their devices. These assumptions, however, were not borne out by their study 
experiences. 
 
“I’m amazed that [devices] have not been sold as far as I know… It was not at all how I expected 
it to go. It was nice as well because it taught me something – so you don’t know everything 




Prior to study commencement, the research team delivered staff training on smoking prevalence and 
harm, EC, local SSS, and supporting the study. The training was well received by those who 
participated in the session and was described as a key facilitator for their engagement with, and belief 
in, the study; staff felt “better equipped” (Staff10, C03, EC) to have more confident discussions with 
clients on smoking, local SSS and vaping. For many, the training facilitated a change in attitude on the 
importance of stopping smoking for their clients, alongside greater motivation to discuss smoking. 
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Some also noted a new understanding of tobacco harm reduction, making the comparison with drug 
harm reduction.  
 
“Doing that training… it made sense because we work with a lot of people with COPD and 
actually smoking wasn’t a priority at all. So the whole study actually has made me rethink… 
it’s the same discussion, part of harm reduction as we have about safer injecting techniques. 
(Staff06, C02, UC) 
 
Our staff sample described having limited prior EC experience and initial ambivalence towards EC. 
Post-training, all reported increased knowledge and interest in EC as a harm reduction and smoking 
cessation aid. Staff in the EC arms appreciated practical, ‘hands-on’ EC training, researcher support, 
and clear, simple handouts. Some said this assisted them in intervention delivery, and also helped 
alleviate initial nervousness at providing the starter kit and instructions.  
 
“The hand out sheets, I think those were the best things. It actually showed you – if you forget, 
this is what [to do].” (Staff02, C01, EC) 
 
Timing of training was important. Some staff expressed concerns about remembering information if 
there was a gap between training delivery and study commencement. Some suggested additional 
advice on local vape shops and vaping policies would be useful. Aware of some participants’ anxiety 
around providing data, some suggested a better overview of the CRF, to give staff greater 
understanding of the types of questions and measures used in the study. Some staff noted that more 
training around facilitating recruitment, approaching participants, and what information should be 
given to potential participants would be useful in communicating the study (see below). 
 
“Going back to the information stage, the recruitment stage. Just having a bit more 
information available for the staff to be able to use as a bit of a prompt. Or as a consistent 
communication style for all of them. I think that would be useful.” (Staff04, C01, UC) 
 
Communicating the study 
How staff communicated the study to participants was one of two deviations from the feasibility study 
protocol. As per the protocol, all participants were to receive the same study information at 
recruitment and complete baseline assessments before being told of their allocation to the EC arm or 
UC. For practical reasons, staff knew whether their centre was allocated to the EC or UC arm. When 
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facilitating recruitment, our sample of staff in the EC arm reported routinely introducing the study as 
an EC or ‘vape study’, where participants would receive a free EC if they signed up.  
 
“I just basically told them, ‘hey listen, I know you are smoking, are you interested in vaping, 
they are doing a smoking study, they are probably giving you free vapes if you are wanting to 
do that.’” (Staff12, C04, 12) 
 
“I did hear some conversations where it was really quite low level, where it was a vape [study] 
and you are going to get the vape.” (Staff04, C01, EC) 
 
Conversely, our sample of staff in the UC arm said they focused their description of the study on 
smoking, quitting and local support, and did not suggest that participants would receive an EC. 
 
“I’m not sure actually I introduced it really well… Just first asking them if they were a smoker... 
if they ever think of stopping and if so, that they could meet with [researcher]… you could help 
them and give them advice on how to stop… I don’t think I even mentioned the e-cigarette. I 
completely forgot about the e-cigarette, because we don’t get it.” (Staff07, C02, UC) 
 
Staff capacity to support the study  
E-cigarette condition 
Few staff capacity issues to support the intervention were described by EC arm staff. There was some 
initial trial and error with setting up efficient processes, but once resolved, facilitating the intervention 
was described as straightforward. High demand for the intervention at Centre 1 led the manager to 
take control of managing referrals and baseline appointments, organising an appointment diary 
consisting of a main and ‘backup’ list, “[Manager] was able to manage it really well from there… just 
one central point” (Staff03, C01, EC). This same model was less successful at the smaller, residential 
units in Centre 4, where there were fewer alternate candidates and less motivation to be disrupted 
from their ordinary activity.  
 
Staff across centres highlighted that weekly follow-ups, where staff provided participants with e-liquid 
and vaping support, could be challenging as some participants lost their appointment cards, did not 
show up at agreed times, or could not be contacted, “it did happen quite a bit – people missing 
appointments, turning up late, turning up early” (Staff03, C01, EC). In Centre 1, implementing a daily 
vaping ‘surgery’ overcame some of these difficulties; however, staff said it could still be challenging if 
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several participants came at once, or did not attend on their set day. Some noted the importance of 
flexibility if participants approached keyworkers at different times, “if someone came in the afternoon 
and I’m free I would issue them the liquids then” (Staff01, C01, EC). One also noted the importance of 
maintaining consistency for the follow-up sessions.  
 
“So what we did was set up a smoking surgery between 10 and 11 every day. So people could 
come along, talk to other people that were vaping, and also get help if they needed it…also 
get their liquids and coils if it was their day to get them.” (Staff03, C01, EC) 
 
Mainly, staff reported responding to participant queries relating to coils “it was just about changing 
the coil… that was the main thing” (Staff11, C04, EC). Some noted requests to help with broken devices 
and suggested staff having access to spare parts would be useful. Some also noted they had been 
asked to open e-liquid bottles due to some participants having poor dexterity. Most staff reported 
receiving few problems with batteries or charging devices. For managing participants’ e-liquid supply, 
some noted that the variety on offer through the study was a good amount, anymore may have 
overwhelmed participants and staff.  
 
“If you give people too much choice, it just becomes a nightmare. So having that restricted 
number I think was absolutely fine.” (Staff02, C01, EC).  
 
Usual care condition 
There were some challenges for staff supporting the UC arm around recruitment and weekly follow-
ups. While some described facilitating recruitment as straightforward, others found this challenging. 
At the day drop-in Centre 2, staff reported that once the small number of regular clients had agreed 
to take part, they had difficulty engaging those who were more transient. While the Love2Shop follow-
up gift cards had been especially important for facilitating UC recruitment, some expressed discomfort 
in their reliance on the gift card as an incentive. 
 
“It was almost like we were encouraging people to do it because they would get a voucher out 
of it. But it just felt a bit uncomfortable if I’m honest…” (Staff06, C02, UC) 
 
Additionally, some reported negative feedback from participants about the length of the baseline CRF 
and the types of questions, and expressed concern about recruiting some people clients to the study, 
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“knowing that actually…it was going to be a challenge for them to answer all those questions” (Staff06, 
C02, UC). 
 
Staff signposting UC services and maintaining weekly follow-up contact was the second main deviation 
from the study protocol. At Centre 3, keyworker staff reported this process worked well. Two staff 
members had escorted their participating clients to local SSS and had attempted to quit alongside 
their clients.  
 
“I escort clients to the stop smoking van, where they can get nicotine patches, all sorts of 
paraphernalia to help them stop smoking… [I’m] still going with them to the van. Every 
Tuesday... we all go for a coffee afterwards as well. So we’ve turned it into a real social event 
actually.” (Staff08, C03, UC)  
 
In contrast, at Centre 2 our interviewees reported some capacity issues to complete these tasks due 
to lack of staff, busy workloads and client demands. Some described dealing with challenges requiring 
immediate attention, rather than resources to focus on stronger client relationships as a factor. 
Finding private space for researchers to conduct baseline or follow-up appointments could also be a 
challenge with rooms often purposed for other support services.  
 
“I have found it, personally, really difficult to do the follow-up… You are always on the go and 
basically I forget... It seems feasible… and then the reality is it hasn’t been… maybe because 
here we don’t keywork as such.” (Staff07, C01, UC) 
 
Staff’s perceived value of the study 
Similar to our participants, staff also placed high value on the study. Across arms, staff appreciated 
the opportunity to become involved in supporting clients’ quit attempts, “it’s really important that we 
are involved in stuff like this” (Staff06, C02, UC). Many highlighted that the study had resulted in 
positive shifts in practice, increasing smoking-related discussions, “I can’t think of any other time we 
had a conversation about smoking with any other client” (Staff12, C04, EC).  
 
“It’s an excellent thing, just being part of this study that is potentially going to inform practice 
and policies and how we deal with smoking amongst the homeless, it’s just immense. The study 
is going to change the way we do things.” (Staff02, C01, EC) 
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While staff at the UC centres were positive about the study and pleased to have taken part, “I feel 
privileged that we were included in this” (Staff03, C03, UC), some expressed less enthusiasm for UC 
cessation support, and disappointment that they had been unable to provide clients with EC, “I think 
getting the e-cigs… I think that would be very helpful for people” (Staff05, C02, UC). 
 
Staff in the EC arm were particularly enthusiastic about the intervention. Many noted positive impacts 
on their clients’ wellbeing. They valued being able to offer clients a tangible, practical tool, rather than 
just offer stop smoking information. Many reported that the intervention had facilitated client trust 
and interactions and boosted staff morale. 
 
“It has brought them to the centre every day, which is good. Building a bit of trust, which is 
always a winner.” (Staff03, C01 EC) 
 
“I think this is a lot more immediate [than other cessation support]. With the attention deficit 
some of our clients have got, to be given something tangible – to be given something, not just 
information, something practical they can use.” (Staff01, C01, EC) 
 
 
Summary of learning points for a future trial 
 
Staff training was key to changing staff misperceptions about smokers experiencing homelessness and 
engaging staff in the study. Recommendations to further improve staff training include: consideration 
of the timing of training in relation to study commencement; advice on local vape shops and policies; 
a more comprehensive overview of the CRF measures and questions; and greater training on 
facilitating recruitment. 
 
For a cluster study design, consideration should be given to how best communicate the study to 
participants, and whether it is practically feasible for participants across arms to be provided with the 
same information at recruitment.  
 
Staff capacity to support the intervention was good at the EC centres and in one UC centre, suggesting 
service providers are well placed to offer stop smoking interventions.  
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Local differences made some study processes more challenging. In one UC centre, lack of adequate 
staffing numbers, a busy environment, and staff supporting people with acute challenges requiring 
immediate attention, rather than in keyworker roles, highlighted capacity issues in signposting to 
usual care and following up participants. Service providers could be further supported by suggesting 
systems for managing referrals, appointments, signposting and follow-ups, taking into account 
differences at each site.  
 
 
Objective 5: Assess the potential efficacy of supplying free e-cigarette starter kits  
Outcome measure: Measure breath CO levels, self-reported quit rates/cigarette consumption at 
each follow-up time point. 
 
Table 5 presents the cessation and smoking reduction outcomes. The CO validated sustained 
abstinence rate at 24 weeks was 3/35 (11%) for the EC arm and 0/12 (0%) for the UC arm. Assuming 
that all those with missing follow-up data were smoking, the 24-week sustained abstinence rate was 
6.25% (3/48) in the EC arm vs. 0/32 (0%) in the UC arm.  
Seven-day point prevalence rates at 24 weeks were the same as sustained abstinence rates.  
 
Of those who returned for 24-week follow-up (not ITT), the percentage of participants who reported 
>50% reduction in CPD from baseline was 43% in the EC arm and 25% in the UC arm. The percentage 
of those with >50% reduction in expired CO was a little lower and similar between groups (EC= 20%; 
UC= 25%).  
 
Table 5: Frequencies and percentages for smoking related outcome variables at baseline and each 
follow-up time point for the e-cigarette (EC) and usual care (UC) arms 
 
 EC Arm UC Arm  
Sustained abstinence   
 4 weeks: N (%) 8/39 (21%) 0 / 21 (0%) 
 12 weeks: N (%) 2/34 (6%) 0/18 (0%) 
 24 weeks: N (%) 3/35 (11%) 0/12 (0%) 
7-day point prevalence   
 4 weeks 7/39 (18%) 0/21 (0%) 
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 12 weeks 5/34 (15%) 0/18 (0%) 
 24 weeks 3/35 (9%) 0/12 (0%) 
50% reduction in CPD   
 4 weeks 21/39 (54%) 4/21 (19%) 
 12 weeks 20/34 (59%) 4/18 (22%) 
 24 weeks 15/35 (43%) 3/12 (25% 
50% reduction in expired CO   
 4 weeks 10/39 (26%) 2/21 (10%) 
 12 weeks 7/34 (21%) 1/18 (6%) 
 24 weeks 7/35 (20%) 3/12 (25%) 
UC: Usual care. EC: E-cigarette. Number of people achieving sustained abstinence refers to abstinence (allowing 
up to 5 cigarettes) since the baseline appointment at the time of follow up. Number of people achieving 7-day 
point prevalence refers to abstinence within the 7-days prior to the defined follow-up period. Number of people 
achieving 50% reduction in CPD (cigarettes per day), calculated as greater than 50% reduction in the number of 
cigarettes smoked per day. Number of people achieving 50% reduction in CO (carbon monoxide), calculated 
from deducting CO at baseline.  
 
Intra-class correlation co-efficient 
The intraclass correlation coefficient was calculated by the Fleiss-Cuzick method 35 and was estimated 
to be 0.0157. The intra class correlation coefficient is the ‘proportion of the total variance in the 
outcome attributable to variance between clusters’35.  Although the estimated ICC is relatively small, 
neglecting to factor this into the sample size calculation for a full-scale cluster randomised controlled 
trial would result in reduced statistical power. 
 
Summary of learning points for a future trial 
Based on the feasibility average recruitment of 16 per month, it would take 24 months to recruit 384 
participants. A main trial would therefore need more (at least double) researchers recruiting and 
collecting data simultaneously.  
 
The estimation of the intraclass correlation coefficient used the Fleiss-Cuzick method and was not 
adjusted for individual level baseline measures. In the full trial, the analysis is likely to be by mixed 
effects models where adjustment for prognostic covariates (e.g. baseline nicotine dependence, 
number of years smoking) is possible. This adjustment for covariates is likely to reduce cluster level 
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correlation in outcomes therefore an estimated ICC of 0.01 is used for the sample size calculation for 
the full trial. 
 
Objective 6: Explore the feasibility of collecting data on contacts with health care services within 
this population as an input to an economic evaluation in a full RCT. 
 
Outcome measure: Record participant scoring on EQ-5D-3L and utilisation of primary and secondary 
health care services using a self-report service-use questionnaire at each time point. 
 
The missing information on EQ-5D-3L was mostly due to absence at follow-up visits. Most of those 
who have attended completed the measure. At baseline, 46 out of 48 participants in the EC arm and 
31 out of 32 participants in the UC arm completed EQ-5D-3L. At 4 weeks, all participants in both arms 
who were followed-up completed it. At 12 weeks, 33 out of 34 attending participants in the EC arm 
and all 18 attending participants in the UC arm completed it. At 24 weeks, 34 out of 35 attending 
participants in the EC arm and all 12 in the UC arm did so. 
 
Among the observed cases, no one reported severe problems in mobility in both arms at any time 
points. The domain with highest percentage of severe problem was anxiety/depression at baseline, 4 
and 12 weeks in both arms, followed by pain/discomfort. At 24 weeks, the percentage was similar in 
the two domains within each arm. The proportion of participants who scored no problem was 
consistently higher in the EC arm than in the UC arm across all domains and all time points. This led to 
a consistently higher mean utility score in the EC arm among those who completed the measure (Table 
6). Among those who completed EQ-5D-3L at all time points, mean QALY was 0.195 (SD 0.097) in the 
UC group (n=11) and 0.315 (SD 0.120) in the EC group (n=26), over 24 weeks. 
 
Table 6: EQ-5D-3L utility and VAS at each time point, by group 





Utility VAS Utility VAS 
Baseline 31 0.394 (0.362) 57.0 (21.7) 46 0.548 (0.341) 52.7 (20.7) 
4 weeks 21 0.330 (0.308) 48.6 (24.7) 39 0.602 (0.346) 61.4 (21.5) 
12 weeks 18 0.350 (0.351) 59.3 (22.7) 33 0.683 (0.309) 65.6 (21.3) 
24 weeks 12 0.619 (0.238) 61.0 (22.5) 34 0.653 (0.363) 61.8 (21.6) 
UC: Usual care. EC: E-cigarette. VAS: Visual Analogue Scale for rating of health today 
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There were three sections concerning services use: SSS use at follow-ups, smoking cessation help from 
primary/community healthcare professionals, and general healthcare services. Overall, most of those 
participants who attended the follow-up visits, completed these sections, with only individual 
participants had item missing on a few questions. 
 
The attendance of SSS sessions was very low in the UC arm. At 4 weeks, four participants out of 21 
contacted SSS. One attended two sessions, three attended one and one did not answer. At 12 weeks, 
two participants out of 18 contacted SSS, one attended one session and the other attended two. At 
24 weeks, two of 12 participants contacted SSS, one attended one session and the other attended 
two. Using the resource impact template for smoking cessation service 36, the unit cost per session 
was estimated to be £12.82. In the UC arm, the mean cost of SSS sessions was £3.21 (SD £9.18) at 4 
weeks (n=20), £2.14 (SD £6.60) at 12 weeks (n=18), and £3.21 (SD £7.97) at 24 weeks (n=12). In the 
EC arm, there was no SSS session cost incurred as none of the participants reported attending any 
session. 
 
At 4 weeks, three of 21 participants in the UC arm used other medications supplied by SSS, including 
inhaler, patches, and lozenges, with a mean cost of £5.68 (SD £14.30) in the arm. At 12 weeks, two of 
18 used patches, lozenges in the UC arm, with a mean cost of £5.43 (£16.01) in the arm. At 24 weeks, 
one of 12 in the UC arm has used gums and patches, with a mean cost of £3.38 (£11.71) in the arm. 
None of the attending participants in the EC arm reported using cessation aids supplied by SSS. The 
majority of them reported using their e-cigarette device only. Among those in the EC arm, who claimed 
not using any aids supplied by SSS or research team, two reported using other e-cigarette device. 
 
No one reported using varenicline or bupropion. No one purchased any NRT product. The purchase of 
EC device or e-liquid was reported by a small group of participants in both arms (Table 7). While the 
number of participants who reported purchase, remained low in the UC arm at all times, the spending 
was higher than that in the EC arm. In the EC arm, increasing number of participants reported purchase 




Table 7: Participants’ purchase of e-cigarette device and e-liquid at follow-ups, by arm 
 UC (n=32) EC (n=48) 
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 n of null 
use 
n (range) when 
use > 0 
Missing n of null 
use 
n (range) when 
use > 0 
Missing 
4 weeks n=21 n=39 
EC device 17 3 (£10-£75) 1 36 3 (£1-£40) 0 
EC e-liquid 15 5 (£5-£168) 1 32 6 (£1-£12) 1 
12 weeks n=18 n=34 
EC device 17 1 (£10) 0 30 4 (£5-£19) 0 
EC e-liquid 15 3 (£39-£448) 0 17 17 (£1-£50) 0 
24 weeks n=12 n=35 
EC device 10 2 (£40-£100) 0 24 11 (£3-£52) 0 
EC e-liquid 10 1 (£288) 2 17 18 (£3-240) 0 
UC: Usual care. EC: E-cigarette. EC e-liquid: E-cigarette e-liquid. 
 
There were very few participants receiving smoking cessation help from primary/community care 
professionals (GP, practice nurse, pharmacist, NHS helpline) and those who did, did not access them 
frequently. Due to the rare and low frequency of use, the costs of smoking cessation help from primary 
healthcare professionals were low and, in some cases, null. Especially for the UC arm, from 12 weeks 
on, there was no one reported any use. The mean costs in the UC arm were £1.45 (SD £6.75) among 
31 participants at baseline, and £5.81 (SD £11.83) among 21 participants at 4 weeks. In the EC arm, 
the mean costs were £3.66 (SD £14.41) among 47 participants at baseline, null cost among 39 
participants at 4 weeks, £1.56 (SD £9.09) among 34 participants at 12 weeks, and £2.11 (SD £12.51) 
among 35 participants at 24 weeks. Overall majority of the costs were contributed by GP advice on 
smoking cessation. 
 
Very few participants reported getting NRT products, mostly on prescription or from SSS. The 
participants who had gotten NRT products all came from the UC arm, with only one exception where 
two participants in the EC arm at 24 weeks also received NRT. In the UC arm, only one or two 
participants at each follow-up point reported getting NRT on prescription or from SSS. At 12 weeks, 
one of those reported four packs of patches and four packs of lozenges in total but five packs of each 
were on prescription or from SSS, causing a discrepancy in quantity. The only one received NRT but 
not on prescription or from SSS was in the EC arm at 24 weeks. Overall, the costs of NRT on prescription 
or from SSS were £1.72 (SD £9.59) at baseline (n=31), £4.13 (SD £18.73) at 4 weeks (n=21), £16.30 (SD 
£51.81) at 12 weeks (n=18) and £11.46 (SD £39.69) at 24 weeks, in the UC arm. In the EC arm, no costs 
of NRT on prescription or from SSS incurred until 24 weeks (n=35), when it was £0.89 (SD £5.26). 
Accepted for publication in Public Health Research published by the NIHR 
 62 
 
Among the general healthcare and social services asked, some services were used by none or close to 
none. Among all participants who have answered in this section, no one received any visit from GP at 
any point of the study. In the UC arm, only one participant received one visit from practice nurse. In 
the EC arm, at 4 and 12 weeks, there was one participant, respectively, who received one visit from 
practice nurse, while at 24 weeks, one participant received two. These were likely due to the homeless 
situation of the participants. No participant accessed maternity service during the study period. Sex 
health clinic was not visited at all at baseline and 12 weeks. At 4 weeks, one participant in the UC arm 
visited sex health clinic twice while two participants in the EC arm visited once and four times 
respectively. At 24 weeks, one participant in each arm visited sex health clinic once. Except for one 
participant in the EC arm at 12 weeks and one in the UC arm at 24 weeks, no other participants visited 
an early intervention team. Both participants visited the team only once. No participant in the UC arm 
stayed in a detox or rehab unit. In the EC arm, one participant stayed in a detox or rehab unit once at 
baseline and 4 weeks, respectively, while the other stayed twice at 12 weeks. 
 
There were low but constant use of emergency and hospital services in both arms. Although majority 
of the responding participants did not report any use, a small group of participants visited A & E 
frequently or had hospital admissions (see Appendix 5). In the UC arm, 4-7 participants visited A & E 
at different time points. The number of visits ranged from one to nine times. In the EC arm, 5-7 
participants visited A & E at different time points. The number of visits ranged from one to six times. 
Due to the design of the questions, we were unable to tell the number of visits that led to admission. 
However, in the UC arm, at least five participants at baseline, two at 4 weeks, one at 12 weeks and 
one at 24 weeks were admitted following the A & E visit. In the EC arm, at least two participants at 
baseline, three at 4 weeks, and one at 12 weeks were admitted following the A & E visit. The highest 
number of hospital outpatient appointments was 10 at baseline in the EC arm. The longest hospital 
stay was 14 days, reported in the UC arm at baseline and 4 weeks, and in the EC arm at 24 weeks. 
 
Most of the participants in both arms received prescriptions. Other more frequently used services 
included GP, practice nurse and adult mental health team. Ten participants in the UC arm and 14 in 
the EC arm accessed drug and alcohol service at baseline. This number dropped to almost none 
afterwards in the UC arm while it remained more or less stable in the EC arm. Similarly, a housing 
team was visited by nine participants in the UC arm and 12 in the EC arm at baseline. The number of 
participants in the UC arm used this service then dropped to one at 4, 12 and 24 weeks while in the 
EC arm, it ranged from 7 to 10 participants at different time points (see Appendix 7). 
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Due to the ambiguous phrase of the question regarding detox/rehab unit, the meaning of ‘visit’ was 
unclear, whether it indicates a period of stay. Consequently, two possible unit costs to quantify the 
number of use were identified: by day or by week. We could not estimate the unit cost of a simple 
visit to the facility. Despite this, the overall mean costs of health care service did not differ much 
because the use of detox/rehab unit was very rare. We therefore reported the higher one of the two 
(by week) to present a conservative number. 
 
The mean costs among observed cases were consistently higher in the UC arm than in the EC arm 
(Table 8). The big difference at baseline and 4 weeks was mostly due to the much longer hospital stay 
in the UC arm. At 12 weeks, although the mean cost of hospital stay was still higher in the UC arm, the 
mean cost of drug/alcohol service and early intervention team in the EC arm offset part of the 
difference. At 24 weeks, the mean cost of hospital stay and drug/alcohol service in the EC arm was 
much higher while the mean cost of A & E, early intervention team and adult mental health team in 
the UC arm was much higher. However, this comparison has to be taken with caution, as around 30%-
60% of the participants in the UC arm lost to follow-up during the study. 
 
 
Table 8: Costs of healthcare and social services at each time point, by arm 
Costs UC (n=32) EC (n=48) 
n Mean (SD) n Mean (SD) 
Baseline 31 £1,480 (£3,188) 47 £518 (£754) 
4 weeks 21 £1,559 (£4,489) 39 £539 (£987) 
12 weeks 18 £957 (£1,849) 34 £682 (£885) 
24 weeks 12 £1,207 (£1,494) 35 £1,172 (£1,952) 
UC: Usual care. EC: E-cigarettes. 
 
Recommendation for future revision of the questionnaire 
The structure and wording of the health-utilisation questionnaire would need to be considered 
carefully if a full trial were to go head. Some of the questions about health-care utilisation were 
confusing for participants, repetitive, or not applicable to everyone in the sample. Others (such as A&E 
admissions) were useful and endorsed by all participants suggesting a more granular follow-up 
question was needed.  
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Objective 7: Estimate the cost of providing the intervention and usual care. 
Outcome measure: Record all resources used in the delivery including staff costs, e-cigarettes and 
other costs incurred. Staff will complete a pro forma to record contact time, non-contact time and 
other resources used in delivery. 
The training for the centre staff to deliver standard support in the UC arm and e-cigarette guidance in 
the EC arm was provided by research team. For the convenience of costing, we divided the training 
into three components: core component, auxiliary component and extra component. 
 
The core component of the training was the group training programme, which was delivered by 
centre, two for UC and two for EC. For the UC arm, it was a 1.15 hours programme delivered by four 
trainers to one centre (seven staff) and three to the other (five staff). The Help to Quit leaflet as used, 
in-house printed at £0.20 each. For the EC arm, the training was slightly longer, taking 3 hours 
(including individual coaching). Each member of staff attended the training was provided with an e-
cigarette device instruction pamphlet and an e-cigarette helpful tips pamphlet, both in-house printed 
at £0.20 each. This was similarly delivered by four trainers to one centre (12 staff) and three to the 
other (8 staff). The demonstration models of e-cigarette were shown to the staff at the ratio of one 
unit per two trainees during the training and six bottles of e-liquid (three flavours with two strengths 
each) were also shown. The e-cigarette starter kit was costed at £20 each and e-liquid was £3 per 
bottle. The research team members who delivered the training were one grade 9, three grade 7 and 
three grade 6. Their hourly costs, including superannuation and national insurance, were calculated 
based on the financial records of the project. The staff who received the training held various roles, 
resulting in varied pay grades. We used the costs information collected from Centre 1 as an estimate 
for all those involved. The time cost of staff was £13.38 per hour, including superannuation and 
national insurance. The costs of staff time in delivering the EC training was £1,040.93 in total and UC 
training was £246.65 in total. There were 20 staff attended EC training and 12 attended UC training. 
Their staff time costs were therefore £802.80 in the EC group and £184.64 in the UC group. The 
demonstration e-cigarette kit and e-liquid was re-used for each training. The maximum number of 
staff for one training was 12. Therefore, the number of demonstration models was estimated to be 
six. Combining with six bottles of e-liquid, the total costs of e-cigarette and e-liquid were £138.00. The 
two pamphlets were printed for all 20 staff attending the EC training, costing £8.00 in total. The 
pamphlets for UC training were printed for 12 staff at £2.40 in total. The costs of core component of 
the training were £433.70 in UC arm and £1,989.73 in EC arm. 
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The auxiliary component of the training included travel, accommodation and meals for those 
delivering and receiving the training. These costs would vary depending on the arrangement of the 
training programme. In this study, we included the costs of these items if they were claimed in 
expenses. For travelling, only train journeys were included. Travelling within a city was not taken into 
account. For the train journeys, the journey duration was estimated using National Rail website 37. It 
was then multiplied by the hourly costs of the personnel took that journey. Centres 3 and 4 were in 
the same city with most of the research team and did not require train travel and therefore the 
travelling expense and time were not costed. The return train journey to Centre 1 costed £29.30 in 
ticket and two hours in time. To Centre 2, the return journey costed £118 (one-way £59) in ticket and 
nine hours in time (4.5 hours one-way). Three team members took a return journey to Centre 1, 
costing £205.83 in travelling time and £87.90 in train tickets. Two team members went to Centre 2 
and had hotel stay. Due to personal arrangements, only one return ticket to Centre 2 was claimed and 
the other was a one-way ticket. This led to £425.97 in travelling time and £177.00 in train tickets. Their 
stay costed £500 for accommodation and £40 for meals. The costs of auxiliary component of the 
training were £293.73 in EC arm and £1,142.97 in UC arm. 
 
The extra component of the training was e-cigarettes given to the staff who were smokers so that 
they themselves could be familiar with the device. This was not applicable to all staff trained, only four 
e-cigarette devices were given to the staff in one centre and two in the other during EC training. In 
total, six e-cigarette devices costed £120. 
 
In total, the training costs for the UC arm were £1,576.66 and for the EC arm £2,403.46. Allocating 
evenly to participants in each arm, it was £49.27 per participant in the UC arm and £50.07 per 







Table 9: Costs of training breakdown 
Costs UC (n=32) EC (n=48) 
Core component 
Delivery of training programme 
£433.70 £1,989.73 
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Auxiliary component 




E-cigarette devices given to staff who smoke 
- £120.00 
Total costs of training £1,576.66 £2,403.46 
Mean costs of training per participant £49.27 £50.07 
UC: Usual care. EC: E-cigarettes.  
 
The delivery of intervention in both arms was recorded in the keyworkers form at baseline (visit 0), 1 
week post-baseline (visit 1), 2 weeks post-baseline (visit 2) and 3 weeks post-baseline (visit 3). Contact 
time was costed by multiplying the staff hourly cost by the duration of the contact. The printing cost 
of ‘Helpful tips’ pamphlets for the UC arm and e-cigarette device instruction pamphlets and e-cigarette 
use tips pamphlets for the EC arm was recorded by the research team at £0.20 each. 
 
Due to staff capacity, the data on delivery sessions were not collected in the UC arm. We therefore 
did not know the attendance of weekly sessions (visit 0-3) and if the pamphlet was given to the 
participants. 
For the EC arm, one participant did not attend any session and did not receive the EC starter kit or e-
liquid. The remaining 47 participants attended visit 0 and received an EC starter kit and five bottles of 
e-liquid. Except for missing answer for one participant, 46 participants also received pamphlets of e-
cigarette device instruction and use tips and their mean session duration of visit 0 was 25 minutes (SD 
16 minutes, range 7-80). Thirty participants attended visit 1, of which 29 received five bottles of e-
liquid and one received two bottles. Except for missing answer for one participant, the mean session 
duration of visit 1 was 8 minutes (SD 4 minutes, range 1-20). Among the 22 participants who attended 
visit 2, 20 received five bottles of e-liquid, one received four and one received 10. Except for missing 
answer for one participant, the mean session duration of visit 2 was 6 minutes (SD 3 minutes, range 
1-15). The number of participants who attended visit 3 was also 22, all of which received five bottles 
of e-liquid. Duration was not recorded for two participants. Among the remaining 20 participants, the 
mean session duration was 5 minutes (SD 2 minutes, range 2-10). 
The mean costs of EC starter kit and e-liquid were £57.46 (SD £19.91) among the 48 participants in 
the EC arm. The mean cost of pamphlet was £0.39 (SD £0.06) among 47 participants in the arm. The 
mean costs of sessions were £7.51 (SD £4.60) among 43 participants. The costs of intervention delivery 
were therefore estimated for 43 participants whose data were complete in this part and it was £64.35 
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(SD £22.89) per participant. In total, the mean costs of EC intervention, including training and delivery, 
were £114.42 (SD £22.89) among 43 participants in the EC arm (Table 10). 
 
Table 10: Breakdown of intervention costs, by arm 
Costs UC (n=32) EC (n=48) 
 n Mean (SD) n Mean (SD) 
Training 32 £49.27 (-) 48 £50.07 (-) 
EC starter kit + e-liquid 32 - 48 £57.46 (£19.91) 
Pamphlet 32 
data not available 
47 £0.39 (£0.06) 
Keyworker session 32 43 £7.51 (£4.60) 
Total 32 data not available 43 £114.42 (£22.89) 
UC: Usual care. EC: E-cigarettes. 
 
Summary of learning points for a future trial 
Whilst it was feasible to collect information relating to the costs of delivery in the EC arm, collecting 
data from staff about contact time was not feasible in the UC arm. If staff are unable to complete this 
information each time they engage with a research participant, approaching them at a quieter time 
(e.g. end of follow-up data collection period at each centre) may improve compliance..  
 
 
Outcomes and estimations  
The outcomes relate only to the results as above, which are specific to the feasibility of a full cRCT.  
  
In respect of estimations for a future trial, based on the findings presented here i.e., proportions with 
sustained CO validated abstinence in each group (6.25% in intervention 0% in usual care) and assuming 
0.05 alpha, 90% power and intraclass correlation coefficient of 0.01, a future cRCT would require 12 
participants per cluster (the feasibility average), 16 sites per arm, totalling 192 participants per arm, 
384 participants across both conditions. This sample size estimate assumes equal cluster sizes. These 
estimates are not adjusted for attrition as it is anticipated that the primary analysis will be by intention 
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Ancillary analyses 
Substance use and mental illness scores were collected at each follow-up point. Mean (SD) scores for 
the mental health and substance use measures for those participants who were retained in the study 
through to the 24-week follow-up are presented in Table 11. GAD7 anxiety and PHQ9 depression 
scores significantly declined steadily from baseline to the 24-week follow-up, though no causal 
association can be assumed. A similar decline in alcohol use as measured by the AUDIT scores was 
also evident, however substance use as measured by the SDS remained stable.  
Table 11: Mental health and substance use tables only including the sample of participants who 
were retained in the study to 24 weeks.  










time = .02; 
main effect 
group < 0.01 
 Baseline: Mean (SD) 10.08 (6.91) 8.48 (6.81) 14.40 (5.36)  
 4 weeks: Mean (SD) 9.11 (6.81) 7.15 6.38) 14.40 (5.02)  
 12 weeks: Mean (SD) 8.27 (7.12) 6.44 (6.54) 13.20 (6.49)  
 24 weeks: Mean (SD) 7.54 (6.64) 5.63 (6.34) 12.70 (4.42)  











time = 0.02 
 Baseline: Mean (SD) 11.53 (8.26) 10.76 (8.34) 13.27 (8.17)  
 4 weeks: Mean (SD) 10.53 (7.62) 9.08 (7.76) 13.82 (6.46)  
 12 weeks: Mean (SD) 9.92 (8.03) 8.36 (7.53) 13.45 (8.37)  
 24 weeks: Mean (SD) 8.25 (7.38) 7.12 (7.22) 10.82 (7.23)  











time = 0.03 
 Baseline: Mean (SD) 10.60 (11.07) 11.83 (12.15) 7.91 (8.08)  
 4 weeks: Mean (SD) 7.86 (9.34) 9.08 (9.76) 5.18 (8.48)  
 12 weeks: Mean (SD) 8.57 (9.72) 10.29 (10.37) 4.82 (7.15)  
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 24 weeks: Mean (SD) 8.00 (8.47) 8.92 (8.83) 6.00 (7.64)  









No sig. effects 
 Baseline: Mean (SD) 3.81 (5.05) 3.15 (4.33) 5.50 (6.52)  
 4 weeks: Mean (SD) 3.19 (4.48) 2.81 (4.51) 4.20 (4.49)  
 12 weeks: Mean (SD) 3.78 (4.15) 3.35 (4.05) 4.90 (4.41)  
 24 weeks: Mean (SD) 3.78 (4.33) 3.23 (4.46) 5.20 (3.82)  
UC: Usual care. EC: E-cigarettes. GAD-7: Generalised anxiety disorder questionnaire. PHQ-9: Patient 
Health questionnaire V9. AUDIT: Alcohol Use Disorder Identification Test. SDS: Substance dependence 
severity test.  
 
Reporting against success/progression criteria 
In our application, we stated that we would continue without modifications to a full trial if the 
following success criteria were met: 
 
1) At least 50% of eligible participants can be recruited within a 4-week period. 
2) No more than 5% of all recruited participants cross from one arm to the other. 
3) At least 50% of all recruited participants complete follow-up assessments 
If we didn’t meet these success criteria, we planned to assess the reasons for this and consider how 
these could be improved in a main trial. We stated that if less than 20% of participants complete 
follow-up assessments, we would consider the main trial unfeasible and would not proceed with a 
future larger trial application. 
 
Success criteria 1 was met; we recruited 52% of all eligible participants. Although we extended the 
recruitment period slightly to 6 weeks at some centres, recruitment was completed within the 
originally specified five-month period and this target was met despite some researchers working part 
time. Further participants could have been recruited at some centres (mainly centre 1) if we had had 
the resources. Success criteria 2 was not met; 67% of UC participants reported any use of an EC during 
the study period. Unfortunately, we did not ask about extent of use so whether it was regular, 
sustained use remains unclear. Although some EC use was reported, none of the UC participants 
received the EC intervention as delivered (i.e. a free EC starter kit offered at homeless centres). 
Contamination across arms can be a problem for many RCTs, however, supported use of an EC is 
increasingly being incorporated into the ‘usual care’ offered by SSS and should not, therefore 
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invalidate our findings. The pragmatic question that will be explored in a main trial (and which this 
feasibility study  sought to provide preliminary evidence for) will be whether the provision of a free 
EC starter kit offered at a location already being accessed by homeless smokers can increase smoking 
cessation rates over usual care. Success criteria 3) was fully met; we exceeded 50% retention at each 
and every follow-up point, however we note that retention did drop below 50% in the UC arm due to 
poor retention at the Edinburgh site. Given that some of our success criteria were not fully met, we 




At the early phases of the study design, our funders panel and PPI work raised several concerns that 
for those presenting with substance use disorders or very little income, free e-cigarette devices may 
be sold, stolen or used for inhaling illicit street trade substances. Therefore, despite a well-intended 
act of offering an e-cigarette, this could invite several unintended consequences.  
 
In order to systemically monitor risk and the occurrence of unintended consequences we developed 
a checklist that participants would be asked at each follow-up assessment. The questionnaire is based 
on our extensive public and patient involvement (PPI), with input from our expert and multi-
disciplinary team, our trial steering group and those working within the third sector. This data while 
recorded retrospectively does not prevent the occurrence of these incidents. The rationale for the 
inclusion of this checklist was twofold, firstly that we could capture number of times these events 
occurred, and secondly to offer support if required.  
 
The rationale for each question based on our PPI work is as follows: 
 
1. Do you still have the e-cigarette that we supplied?  
To ascertain whether the participant was still in possession of the product that had been supplied 
to them as part of the study. It was raised during our PPI consultation work that adults who are 
not securely housed or sharing residences may easily lose their e-cigarette, have it stolen or sell 
it.  
 
2. (If no) Since our last meeting has your e-cigarette been lost, stolen, sold, exchanged?  
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We are seeking here to gather information as to what happened to the device. Understanding if 
people are retaining their e-cigarette can help with future planning for more definitive studies or 
service provision.  
 
3. If yes, to any of the above, please provide details: 
Free text responses for the participant to elaborate and give the study team more information 
related to the event. By collecting more detailed information, study teams can try to further 
mitigate against risks such as theft and understand the nature of the event (e.g., coercive theft) 
surrounding the incidents.  
 
4. Have you added any of the following to your e-cigarette? 
A frequent concern when designing the study was that participants may use the e-cigarette for 
vaping substances other than e-liquid. Here we aim to capture if the e-cigarette is being used for 
vaping any other substances and which ones.  
5. Have you used the e-cigarette for any other purposes?  
To monitor unforeseen or unpredicted use, we were advised to include this question to capture 
a broad range of usage.  
 
6. For you, does the experience of using an -cigarette have any other similarities to drug use 
(for example, crack)? 
Although not common, in our scoping and PPI work, a small number of clients from homeless 
centres commented that for them use of a pen-like second generation e-cigarette triggered 
memories of historic crack cocaine smoking owing to device shape and the sensory aspect of 
inhalation.  
 
The majority of the participants used the device as intended. Table 12 presents frequency and 
percentage data at each follow-up point.  
 
 





(since 4wk FU) 
 
24-weeks 
(since 12 wk FU) 
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Yes No N/A Yes No N/A  Yes No N/A 
Still has EC? 33 (41) 6 (7.5)  28 
(35) 





















Sold: N (%) 0 39 
(81.3) 










1 (2.1) 38 
(79.2) 








Given away N (%) 0 39 
(81.3) 




























substance? N (%) 
0 39 
(81.3) 




2 (2.5) 32 
(40) 
12 (15) 
EC used for any 
other purpose? N 
(%) 
1 (1.3) 38 
(47.5) 




1 (1.3) 33 
(41.3) 
12 (15) 
EC has any 
similarities to 
drug use?  
 




2 (2.5) 32 (40) 46 
(57.6) 
2 (2.5) 32 (40) 46 
(57.6) 
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E-cigarette, lost, stolen or exchanged 
At 24-week follow-up, 63% still had the EC we provided. Across the follow-up period there were only 
7 individual incidence of e-cigarette loss, 6 reported thefts and nobody reported selling their device. 
Although 1 person did report exchanging their device at 4 weeks and 3 people gave their device away. 
Other reasons why people did not have their device was because they didn’t like it taste or feeling (n 
= 2) or reported accidentally leaving it elsewhere (n = 5), one person reported having it confiscated 
upon admission to hospital.  
 
There was a high percentage of breakages, across the follow-up times breakages were reported on 
average 25% of the time. The most common breakage reported was cracked glass tanks.  
 
Adding of other substances 
There were two reports across the follow-up period of adding other substances not intended for 
vaping. At 24-weeks one person reported adding THC and another CBD oil, however these were added 
to other devices, not the devices that were provided in this study, suggesting that regular second-
generation e-cigarettes as provided here may not be compatible with vaping other substances. 
Use of the e-cigarette for any other purposes 
At all follow-up appointments, the majority of people said they had not used their device for any 
other purpose. At 4-week, one person reported using it to mimic vaping without actually switching 
the device on (“I put my lips on it”). There were no reports of unintentional use at 12 weeks. At 24-
week follow-up, one person reported using it as both a back scratcher and attempted to use it to 
light a cigarette.  
 
Similarities to drug use 
The majority of participants reported no similarities to drug use experiences. However, two did. One 
participant noted at all 3 follow-up points that using the device was similar to crack use, and one 
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Presented here is the first UK feasibility study with an embedded qualitative process evaluation 
exploring smoking cessation within the context of smokers accessing homeless centres; and the first 
known trial with adults experiencing homelessness on the use of e-cigarettes for cessation. This report 
presents data on participant recruitment, retention, engagement, service capacity, perceived value 
and preliminary efficacy and cost-effectiveness. The initial results are promising, and with careful 
consideration and future PPI and stakeholder (homeless charity) input, a future trial may be feasible 
with some   changes to the structure and delivery of the intervention. We discuss the facilitators and 
barriers in more detail below, including recommended changes needed to progress to a main trial.  
  
In relation to our first objective, recruitment, of all those who were eligible, just over half of those 
invited agreed to take part and completed the baseline assessment. Only one person withdrew from 
the study. Our process evaluation has provided useful information which has helped us to understand 
how to increase participant trust and therefore willingness to take part in a future trial. One stand out 
point relates to participant vulnerability and nervousness in taking part in research and sharing 
personal information. The longer we stayed at centres – especially centres 1 and 2 – the more likely 
service users were to engage and wished to take part, representing growing trust and a ‘snowball 
effect’ as other service users were seen to be taking part and speaking to the research team, though 
this also had the unintended consequence of ‘unblinding’ centre allocation. In terms of future work, 
this highlights the need for the research team to introduce the study to service users as well as staff 
before baseline assessment. Building trust and offering the opportunity to be seen and be known 
should, as per our qualitative interviews, decrease any concerns around confidentially and 
misperceptions about the nature of the study.  
 
In addition to this, the type of centres taking part in this trial and in a future full cRCT is important. 
Day centres, defined as those which offer services within usual working hours, were the more 
successful in terms of recruitment compared with residential units. Specifically, the two-day centres 
(centres 1 and 2) accounted for 77.5% of the total sample.  The research team and the participants 
themselves observed that within the context of these services, a study taking place or a new service 
being offered was not particularly out of the ordinary. Both of these day centres already offer a range 
of services and support; thus, our study was within the realm of what was being offered. Furthermore, 
as noted by our participants when discussing the differences between centres, the day centres offered 
access to potential participants, who by virtue of their presence at centres, were already engaged with 
the service. At the residential units there was notably less activity and a significantly lower footfall of 
potential participants. Contrary to expectations, recruitment and follow-ups were not easier at 
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residential units as compared to day centres. Residents who were ‘at home’ would often not respond 
to door-knocking or would reply that they did not want to be disturbed, whether or not they had 
scheduled appointments and reminder messages. Offering the service within residential units at times 
felt more intrusive and this needs to be considered for future studies. It should also be noted that 
there were fewer smokers within the residential units, and more people were at work. This point is 
important for considering targeting the most vulnerable smokers; it should not be assumed that 
because these adults are facing homelessness that the levels of need will be the same across the 
population.  
 
Centre 1 (EC) was the most successful in terms of recruitment and retention. There were very few 
limitations to this centre, but it was observed by the researcher that, although its scale was positive 
for recruitment, it was also often busy and there could be disturbances. Disturbances and commotion 
were common within both day centres. For example, at Centre 2 (UC), it was common for events 
outside of the staff/researchers’ control (e.g., arguments, drug poisoning, other urgent needs) to take 
over, making it difficult, or at times impossible, to recruit, collect data and elicit staff support for the 
study. Despite this, with flexible researchers and a good connection between the research team and 
the centre staff, these problems were overcome and by extending the recruitment period to 6 weeks 
rather than 4, we were able to recruit 22 people. Follow-up was difficult at Centre 2 for the reasons 
outlined above but also because many of the participants were not able to come back for follow-up; 
many had moved on, or were not visiting the centre during the follow-up period. The lower follow-up 
rate at Centre 2 compared with Centre 1 may also reflect baseline differences between the groups 
and the fact that Centre 2 was within a busy national capital city centre with a highly transient 
population. 
 
The two residential units had the lowest recruitment rates, despite extending our recruitment period. 
Centre 3 (UC), despite being known as a ‘centre’, comprised three geographically separate sites and 
residents did not congregate in the communal spaces much when our researchers were present. Even 
during periods of good weather, very few people sat in the gardens, often leaving the site or staying 
in their rooms, in some cases being active at night and sleeping during the day. A number of potential 
participants were out in the daytime, attending day centres, jobs, part-time education, health 
appointments, or volunteering. This is in comparison to the bustling environments and continual foot 
fall of the day centres. In addition to this, with Centre 3 being located at three different locations, the 
opportunities to ‘fill’ unattended appointments or serendipitously ‘catch’ one person whilst waiting 
for another were fewer than at Centres 1 and 2 where the scale of daily interactions and activities was 
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greater. Likewise, there were far fewer interactions between residents, so there was less effect from 
word-of-mouth, even related to the opportunity to receive an incentive gift card.  
 
Similarly, Centre 4 (EC) had four separate sites at three geographically separate locations. Generally, 
the residents we met who smoked at this centre had consistently complex needs (e.g., substance use 
and severe mental health comorbidities and side-effects from prescription medications). There were 
few structured communal interaction events and where these did exist, take-up by residents was low. 
Participation in activities such as coffee-mornings was moderate but more often attended by people 
who were already non-smokers. Newly hired staff had already-full workloads with inductions, 
compulsory training, and patterns of shadowing colleagues, so were not able to prioritise supporting 
the research as much as had been anticipated at the planning stages. At the women-only 
accommodation (one site making up centre 4), there were no private meeting rooms for data 
collection or meetings, so all data collection was conducted in the multi-purpose room. This was 
challenging at times due to the lack of privacy, as the garden and residents’ units were accessed 
through the multi-purpose room. These are wider considerations which would need to be taken into 
account for a future trial by planning with centres how the study is needed to run and what the 
conditions for a ‘good assessment’ look like.  
 
However, despite some expected and unexpected challenges, that we were able to recruit 80 
participants across four centres in a five-month period despite the limited pool of participants at the 
residential centres, is encouraging. . We are especially encouraged given that our participants 
presented with a high prevalence of mental illness and illicit substance use.  
 
Retention was also assessed for a future trial. The overall 24-week total retention rate was 59%, this 
compares well with other studies which have recruited smokers from homeless services4. Indeed, here 
we add to the growing evidence base that despite many competing needs, the majority of our 
participants were willing to come and speak to the research team.  As reflected in our qualitative 
process evaluation, the financial incentive was instrumental in securing a sufficient number of people 
within the trial and moving forward the incentive system should remain in place. Financial incentives 
have been used widely across smoking cessation studies within this environmental context and have 
also been shown to be a direct measure of increased participation4. 
 
Results show that 24-week retention rates were higher in the EC arm compared to the UC. There are 
several explanations for this. Firstly, the EC arm received weekly sessions to provide e-liquid for the 
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first 4 weeks. This differential level of contact may have encouraged retention in this arm. 
Nevertheless, this is unlikely to be a key factor given that 4-week retention rates did not differ 
dramatically between arms (81% vs. 66%). Secondly, baseline characteristics indicate that our UC arm 
presented with a with greater mental health and substance use comorbidities, both in terms of 
incidence and severity. This may be a consequence of our non-randomised design, however, the 
differences across arms appeared to be mainly due to higher levels of anxiety and especially substance 
dependence and cannabis use at centre 2 in Edinburgh which were significantly higher than at any 
other centre (which did not differ from each other). This is likely to impact attendance due to 
competing health and social needs and indeed, this centre was associated with far lower 24 week 
follow up than the other three. This sample (at centre 2) was also especially transient in nature, and 
it was difficult to keep in touch with the participants by 24 weeks (some of whom had been 
hospitalised or incarcerated). Nevertheless, it is encouraging that individuals with such high-level 
needs were willing to take part and provides proof of concept of the wide-reaching engagement of 
this study. Future research with this population would need to work closely with PPI representatives 
in order to explore how participants could be retained in research trials.  
 
However, for those who did return, 6% achieved sustained CO-verified abstinence rate at 24 weeks 
(intention to treat) in the EC group compared to 0% in the UC group. Cessation rates are low and our 
sample size is small but these are in-line with other studies conducted in similar settings 16. Our study 
is however the first study to also monitor continuous abstinence at 24-week follow-up within this 
population, the general trend has been to capture 24-hour or 7-day point prevalence at 6-months 4. 
Given that we have measured continuous abstinence our results compare favourably to two similar 
trials using NRT, 4% reported at 26 weeks by Segan et al. 38, and 5.6% and 9.3% 7-day point 
prevalence at 26 weeks in a larger sample of 430 smokers receiving NRT and motivational 
interviewing+ NRT at a homeless centre respectively 16.  
 
Importantly, we were able to collect the data from our participants that would be needed for a full 
cRCT and to include a full economic evaluation (although see below regarding contact time with staff 
in the UC arm). Amendments can be made to the questionnaires which allow for less extensive 
intrusion of people’s background and current lived circumstances, but at the same time still allow the 
relevant data on health and demographics to be collected.  
Completion rates of HRQoL and general healthcare and social services questionnaires suggest that the 
use of these measures was feasible whilst indicating potential areas for the refinement of data 
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collection. More detailed data collection will be included for services used frequently by this 
population, whereas services with little use can be omitted from the final data collection pro forma. 
Self-reported SSS use showed that few participants in the UC arm sought SSS for quitting and they did 
not ask for help from GP services after 4 weeks. In the EC arm patients did not seek any SSS during the 
study period and instead used GP services when they were no longer offered help by their keyworkers 
in the centre.  
Overall feedback from participants about the study was positive, as noted above (Harms) there were 
very few unintended consequences and as noted by the qualitative process evaluation, and the 
experience of being offered an e-cigarette and use after assistance was well received. Encouragingly 
the majority of participants reported that they still had and were still using, though not exclusively, at 
24-week follow-up. This is an important issue for breaking stereotypes that this may be a group of 
adults who will not be able to keep in possession of an e-cigarette. There were extra signs of 
encouragement in the form of participants purchasing their own products, which can be taken as a 
personal investment in vaping. Around a third reported having purchased their own e-cigarette, this 
may also explain why the number of participants reporting having used an e-cigarette was greater 
than the number having been originally supplied.  
 
EC use was also commonly reported in the UC arm; around two thirds reported that they had used, 
and one third had purchased an EC at some point during the study period However, we did not explore 
the extent nor the frequency of this use. Use of an e-cigarette is not uncommon in smokers 
experiencing homelessness 3914 and use and experimentation is prevalent amongst the general 
population of smokers in Great Britain 40. As has been reported elsewhere, cluster designs cannot fully 
mitigate the occurrence of EC use in UC and in fact, EC use is beginning to be supported or actively 
encouraged in SSS under ‘usual care’. Although there was some EC use in our UC group, no participants 
experienced the EC intervention ‘as delivered’ in the EC arm (i.e. a free EC starter kit + liquid offered 
at homeless centres).  
 
Staff capacity to support the study was generally good and staff across three of our four centres 
reported few issues in the process evaluation interviews. The additional responsibilities placed on staff 
in the EC arm including initial device set-up, administration of e-liquid and general participant support 
were met well by the staff in our study. The high value that staff and management placed on the EC 
intervention likely helped to better engage staff in these processes. Staff training on EC and researcher 
support were also important in building staff belief in EC as a harm reduction tool and developing their 
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confidence for EC intervention delivery. This helped staff overcome initial nervousness at supporting 
participants to use their EC. As the study progressed staff concerns surrounding EC were alleviated, 
for example, they reported receiving few problems regarding batteries or charging devices and they 
were able to manage participants’ e-liquid supply well during the intervention phase. Although some 
of our participants would have welcomed a greater variety of e-liquid, staff were content with the 
quantity of different e-liquids on offer, which needs to strike the right balance between participant 
choice and staff ability to administer.  
 
Daily challenges for service delivery, particularly those experienced at the busier drop-in centres, 
highlight that service providers may need further support by providing efficient and effective 
processes for facilitating the study alongside their usual work. While daily challenges were similar for 
the drop-in centres (Centres 1 and 2), Centre 1 was better able to support the study through having 
better resources to draw upon, including staffing and space. Lack of adequate staffing and space 
presented some challenges for the study at Centre 2. While staff at Centre 1 could cope with and 
support the high level of interest in the study from clients, staff at Centre 2 were not able to facilitate 
participant signposting to SSS or follow participants up weekly to check their engagement with SSS 
and where they were able to, we could not collect data on this. Busy workloads and client demands 
primarily accounted for reduced capacity for staff to support the study at Centre 2 and alternative 
ways of capturing contact time in order to fully cost UC would need to be considered if moving to a 
full trial.  However,  it is also possible that a lower value placed on the UC intervention may also 
account for lower staff engagement with these aspects of these study. Service providers could be 
further supported by suggesting systems for managing referrals, appointments, signposting and 
follow-ups, taking into account the differences at each site. Training for staff in the usual care arm 
could also encourage them to see benefits of UC support. 
 
The qualitative interviews found perceived value of the study and EC intervention was high among 
participants. Given participants’ reported desire to change their smoking behaviour, irrespective of 
whether their primary goal was cessation or harm reduction, the chance to engage in smoking-related 
discussions was welcomed. That this opportunity could be accessed at a place where participants 
resided or regularly attended, and was incentivised through provision of the EC starter kit and/or 
Love2Shop gift cards was an added bonus for participants, facilitating their engagement despite low 
expectations for behaviour change. Those in the EC arm who took part in an interview were 
particularly enthusiastic about the EC intervention with strong belief in the value of EC as a harm 
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reduction tool. Social dynamics, especially at Centre 1, where some individuals with social standing 
became vaping advocates, contributed greatly to this belief. This contrasted with the lower perceived 
value of the UC approach, which largely stemmed from previous negative experiences of NRT, and 
likely accounts for the poorer engagement with local SSS. That many in the UC arm expressed interest 
in EC as a result of the study may also provide an explanation for the level of contamination across 
study arms.  
 
Limitations 
We did not meet the original recruitment target we set ourselves of 120. However, this was a 
pragmatically chosen target based on our early scoping work and there was potential for further 
recruitment from some sites if our schedule had permitted it. A second limitation was that we were 
not able to randomise clusters to condition as planned and this may have led to the differential 
retention rates which were lower in the UC arm. Our arms also differed on some important baseline 
characteristics which may have contributed to the lower retention rates at UC sites. This was 
particularly the case for centre 2 in Edinburgh which differed to the English sites on many of these 
baseline variables. A fully powered randomised cluster design stratified by region in a main trial should 
mitigate against baseline differences across groups. Blinding was not possible for the assessment of 
outcome measures which may have led to assessment bias or reduced effort in attempting to contact 
some participants for follow-up. Furthermore, staff working at the centres were not blinded to 
intervention arms and this could potentially have introduced some bias, for example, staffs beliefs 
around who would be interested and most able to take part, not least beliefs around who would 
attend and quit. Finally, we were unable to collect information in the UC arm around staff contact 
time with research participants.  
 
The qualitative process evaluation has some additional limitations. Due to the small sub-sample of 
trial participants and sample of centre staff, the qualitative findings may not be representative of all 
our trial participants or staff involved in supporting the study. As above, it is possible that those 
agreeing to take part in an interview may have held stronger views of the EC or UC intervention, 
however, many of our interviewees in the UC arm had not engaged with UC support, reflective of the 
wider trial sample. As such, the qualitative process was not able to fully detect any potential bias 
across intervention arms. We had difficulty recruiting 4-week non-completers to take part in an 
interview, primarily as a result of challenges in maintaining contact rather than a reluctance to take 
part. While interviewing a greater number of non-completers may have identified further barriers to 
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engagement, interview narratives of the small number of non-completers who did take part were not 
substantially different to the majority of the sample.  
 
Generalisability  
Our data derive from three geographically distinct areas of the UK and from a variety of different 
centres. The demographics of our are similar to the wider UK population experiencing homelessness 
(see: https://www.homeless.org.uk/facts/understanding-homelessness/impact-of-homelessness) 
although the percentage in current employment was lower, and the percentage experiencing long-
term physical health problems and using drugs, was higher than reported in the UK homeless 
population by homeless.org. Based on these facts, and although centre staff recruited those who were 
known and actively engaging with the services, it does not appear that our sample was any less 
disadvantaged than the UK homeless population as a whole. The sample is small relative to the 
numbers of people engaging with the homeless sector but we see no reason why the results and 
methods here cannot be generalised to other homeless service settings as a potential area for future 
work. Furthermore, as mentioned above, it is important to stress that our sample included those with 
both current and historical substance use and mental health comorbidities meaning that our 
participants presented with the complex needs which one expects within these services. It is 
encouraging that we are able to reach participants from a wide range of backgrounds with differing 
levels of needs. Central to DHSC’s vision of reducing smoking prevalence rates is directly tackling 
smoking where tobacco related health inequalities are most felt by driving smoking rates down 
amongst groups with a high incidence of social disadvantage. This work provides a baseline for that 
vision. This feasibility provides proof of concept that even amongst adults with complex and 
competing needs there is a desire to take part in cessation research and attempts to quit are good, 
our participants did use and hold on to their EC. Encouragingly, overall, the intervention was well 
accepted and provides a baseline for future work.  Specifically findings, suggest that a fully powered 
cRCT to explore efficacy and cost-effectiveness may be feasible but in order to fulfil this, recruitment 
across multiple sites must be considered against service provision type and plans for retention need 
to be explored to increase follow-up rates. A larger trial is important  to establish a stronger evidence 
base for smoking within this population and work towards the shared vision of reducing smoking 
prevalence within adults experiencing homelessness.  
 
Research recommendations  
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Objective 1: Recruitment – assess willingness of smokers to participate. The residential units had 
fewer eligible individuals and potential participants were less available and less interested in taking 
part in research. Recommendation: Any future study should ensure sufficient researchers are 
employed on the project to deal with recruitment and explore limiting sites to day centres only. This 
is especially important given the transient nature of the population, staff may need to be responsive 
to the availability of the participants.  
 
Objective 2: Assess retention and engagement in the EC and UC arms. Retention rates were moderate 
to good and were comparable to other studies in deprived groups, however one site’s poor retention 
rates negatively skewed retention rates. Recommendation: In designing a future trial, we advise 
based on our findings, that a larger number of clusters with fewer people at each one and official 
randomisation should help to reduce residual confounding factors between the groups. 
Randomisation should also ensure that variables predicting drop out are equally distributed between 
groups thus reducing the difference in retention across arms. 
 
Objective 3: Examine the perceived value of the intervention, facilitators and barriers to engagement. 
Perceived value of the intervention was high. Barriers were participant’s personal and psychological 
difficulties especially in relation to answering the questionnaires, a sense of nervousness around 
research, cannabis use and staff assumptions about smoking. Facilitators were participant’ desire to 
change, lack of existing cessation support, free EC and social dynamics. Recommendation: Future 
studies should make to time to introduce the research team to the participants and outline the project 
to the service users (all those who access the service, who may or may not take part in the study). 
Researchers should also identify opportunities to increase trust and build relationships before 
recruitment. We strongly recommend reconsidering questionnaire burden and intrusiveness; 
including shortening some questionnaires. Future work should also seek to understand what person 
centred language would be most appropriate and acceptable with users of homeless services – there 
is currently a dearth of literature on this.   
 
Specifically for intervention studies which include staff training, from our own experiences, we suggest 
adding an element to the staff training on fostering a community around the study, highlighting the 
benefits this brings to motivation. Qualitative work should be designed to fully capture service user 
and staff views in their experiences of taking part in research studies, including barriers but also 
facilitators, this would complement our own findings and develop this evidence base.  
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Objective 4: Assess service providers’ capacity to support the study and the type of information and 
training required. Overall, in the EC arm, staff were well equipped to support the intervention with 
few capacity issues. Although there was some evidence that staff misremembered key points from 
the EC training and facts around their use. Some challenges were highlighted in one UC centre, but 
this is reflective of the unique challenges of this centre and not the UC intervention. 
Recommendation: If a full trial was successfully awarded, planning randomisation and a larger 
number of clusters should reduce any similar issues. Furthermore, fewer participants at each cluster 
will the reduce burden on recruitment and follow up at each centre. A future trial should also explore, 
top-up staff training with smaller, intermittent sessions, especially at EC centres. 
 
Objective 5: Assess the potential efficacy of supplying free EC starter kits. The offer of a free EC starter 
kit was well accepted by staff and participants. Using ITT analysis, we found sustained 24 week 
abstinence rates of 0% in the UC arm and 6.25% in the EC arm which provides preliminary evidence of 
potential efficacy, however, the absolute numbers were small (3/48 in the EC arm and 0/32 in the UC 
arm). The UC sample size was also lower than expected; the 0% abstinence rates may therefore be an 
under-estimate of true cessation rates with UC.  Recommendation: In order to definitively measure 
efficacy, a future trial with smoking cessation rates as the primary outcome should include more 
clusters with a fully-powered sample size perhaps using a slightly higher abstinence rate with UC (e.g. 
0.5-1%). To fully understand the mechanisms through which change occurs, we recommend an 
embedded process evaluation which seeks to explore fidelity of implementation and treatment 
context.  
 
Objective 6: Explore the feasibility of collecting data on contacts with health care services. Almost all 
participants who were present at follow-up visits completed data collection for healthcare service 
utilisation and health-related quality of life measures, however as reflected in our interview data, 
some participants found the nature of these intrusive or overly complicated. Recommendation: 
Alongside experts with lived experience, in any future trial, should consider the structure and wording 
of the health-utilisation questionnaire. 
 
Objective 7: Estimate the cost of providing the intervention and usual care. Whilst it was feasible to 
collect information relating to the cost of delivery in the EC arm, collecting data from staff about 
contact time was not always possible in the UC arm. Recommendation Alternative ways of capturing 
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contact time (or supporting staff to capture contact time) should be considered (e.g. improving 
reporting mechanisms or collecting data at a quieter time such as the end of follow up data collection 
period at each centre) in order to fully cost UC.  
 
Conclusion  
This study focused on a group of people who are not well considered in traditional smoking cessation 
treatments and despite some issues around recruitment and retention, there is promising evidence 
that a full trial may be feasible with iterations to the main trial design and with further discussion with 
project partners. We observed early signs of acceptability and potential efficacy of offering free EC 
starter kits. Centre staff were a crucial element in helping people to take part in the study, training 
helped to support staff in how to be involved in the study and building trust between the researchers 
and the participants was also key. However, the study was challenging in some sites and parts of the 
delivery of the study need to be optimised so we can plan a trial which would be likely to progress 
fully through a clear stop/go criterion. In considering this, and planning to mitigate against future 
issues, we will explore the findings from the process evaluation alongside the quantitative data, so to 
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Appendices  
Appendix 1 CONSORT flow diagram 
 
 
































Assessed for eligibility (n=106) 
Excluded (n= 29) 
  Not meeting inclusion criteria (n= 8) 
  Declined to participate (n=31) 
  Other reasons (n= 0) 
 
Analysed (n= 48 ) 
 Excluded from analysis (n= 0 ) 
Lost to follow-up (in hospital, lack of sleep, side effects of 
medication, and as at 4 weeks) (n=13 ) 
Discontinued intervention (n= 0) 
Lost to follow-up (in hospital following assault, in prison, 
reported to move city, several not seen for several weeks, 
stopped attending because partner was attending centre, 
and as at 4 weeks) (n= 12 ) 
Discontinued intervention (as above) (n= 1) 
Analysed (n= 32 ) 




Assessed for eligibility (n=71) 
Enrolment 
Lost to follow-up (in prison, lack of sleep, side effects of 
medication, and as at 4 weeks) (n=14 ) 
Discontinued intervention (n= 0 ) 
Lost to follow-up (did not want to engage, in prison (1), did 
not respond (1), not been seen since baseline, moved on/ 
moved city, and as at 4 weeks) (n= 18) 
Discontinued intervention (as above) (n= 1) 
Follow-Up T3 
24 weeks 
Lost to follow-up (reported moved out of the area, stopped 
attending service, not responding to text messages or 
phone calls, not motivated to attend) (n= 8) 
Discontinued intervention (n= 0) 
Lost to follow-up (not seen again, mobile number no longer 
in use, ‘not in the right frame of mind’, not motivated to 
attend) (n= 9) 
Discontinued intervention (‘I’ve got too much going on’ 
related to police involvement) (n= 1) 
Follow-Up T1 
4 weeks 
Allocated to intervention (EC) 
 Centre 1: Day centre 
 Centre 4: Temporary accommodation 
Allocated to control (UC) 
 Centre 2: Day centre 
 Centre 3: Temporary accommodation 
Centre Cluster 
Allocation 
Allocated to intervention (n= 48) 
 Received allocated intervention (n= 47) 
 Did not receive allocated intervention (left 
before keywork and did not return) (n= 1 ) 
Allocated to intervention (n= 32) 
 Received allocated intervention (n= 31) 
 Did not receive allocated intervention (left 
before keywork and did not return) (n= 1 ) 
Allocation 
Excluded (n= 58) 
  Not meeting inclusion criteria (n= 16) 
  Declined to participate (n= 16) 
  Other reasons (n= 26) 
 
Analysis 




Appendix 2: Participant selection of e-liquid flavours and nicotine concentrations  
 
Flavour & strength Baseline Visit 1 Visit 2 Visit 3 TOTAL 
      
Tobacco 18mg 34 10 8 2 54 
Tobacco 12mg 38 14 13 17 82 
Menthol 18mg 22 16 17 17 72 
Menthol 12mg 25 27 17 14 83 
Fruit 18mg 59 29 17 16 121 
Fruit 12mg 60 51 42 44 197 
TOTAL 238 147 114 110 609 
 Milligrams are expressed per 100 mL.   











Centre and feasibility study  arm    
Centre and feasibility study arm  
 
4 
  Centre 1, EC arm  7 (31.8%) 3 
  Centre 2, UC arm  6 (27.3%) 3 
  Centre 3, UC arm  4 (18.2%) 2 
  Centre 4, EC arm  5 (22.7%)  
Completion at week 4 follow-up  
 
 
  Completer   19 (86.4%)  
  Non-completer  3 (13.6%)  
Smoking at 4-week follow-up   17  
  Yes    18 (81.8)  
  No    1 (4.5%)  
  Missing   3 (13.6%)  
Sex     
  Male   13 (59.1%)  
  Female   9 (40.9)  
Age (years)  
   
 






   
 
  White UK 
 
13 (59.1%)  
  White other  
 
2 (9.1%)  
  Mixed white and Caribbean 
 
1 (4.5%)  
  Mixed white and African  1 (4.5%)  
  Mixed other  2 (9.1%)  
  Black African, Black British African 
 
2 (9.1%)  
  Black Caribbean, Black British Caribbean 
 
1 (4.5%)  
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Where slept last night    
  Hostel or supported accommodation 12 (54.5%)  
  On someone’s sofa or floor 2 (9.1%)  
  Emergency accommodation 2 (9.1%)  
  B&B accommodation 1 (4.5%)  
  Housed – own tenancy 5 (22.7%)  
Long standing illness or disability   
  Yes 18 (81.8%)  
  No 4 (18.2%)  
Previous mental health hospital admission   
  Yes 10 (45.5%)  
  No 12 (54.5%)  
 
UC: Usual care. EC: E-cigarettes. SD: Standard deviation.  
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Appendix 4: Unit costs of prescribed NRT products 
NRT product Unit cost (2018/19) Sources 
Patches £26.70/item (Prescribing Medicines 
Team 2018, Curtis and 
Burns 2019) 41,42 
Gum £13.85/item 
Tablets £18.70/item 
Inhaler £0.80/cartridge; £36.40/item 
Lozenge £14.79/item 
Nasal spray £15.55/bottle 
Mouthstrip £10.23/item 
NRT: Nicotine replacement therapies 
 
 
Appendix 5: Unit costs of smoking cessation and health care services 
 Unit cost (2018/19) Sources 
Smoking cessation help from primary care professionals 
GP £37/10-min session (Curtis and Burns 2019) 42 
Practice nurse £8/10-min session (Curtis and Burns 2019) 42 
Pharmacist £8/10-min session (Curtis and Burns 2019) 42 
NHS helpline £6/call (Curtis and Burns 2019) 42 
Health care and social services 
A & E £192/attendances (NHS England and NHS Improvement 
2020) 43 
Outpatient £144/appointment (NHS England and NHS Improvement 
2020) 43 
Inpatient (nights) £642/night (NHS Improvement 2018, NHS England 
and NHS Improvement 2020) 43,44 
Day case £752/case (NHS England and NHS Improvement 
2020) 43 
Ambulance (travel) £257/journey (NHS England and NHS Improvement 
2020) 43 
GP £34/9.22 min consultation (Curtis and Burns 2019) 42 
Practice nurse £11/15.5 min consultation (Curtis and Burns 2019) 42 
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 Unit cost (2018/19) Sources 
GP (home visit) £79/9.22 min 
consultation+12 min travel 
(Curtis and Burns 2019) 42 
Practice nurse (home 
visit) 
£19/15.5 min 




£20/prescription (NHS Prescription Service 2019) 
Sex health clinic £263/visit (NHS England and NHS Improvement 
2020) 
Drug/Alcohol service £113/visit (NHS England and NHS Improvement 
2020) 
Early intervention £2721/patient-year (Curtis and Burns 2019) 
Adult mental health 
team 
£155/contact (NHS England and NHS Improvement 
2020) 
Crisis team £87/contact (NHS England and NHS Improvement 
2020) 
Maternity service £232/contact (NHS England and NHS Improvement 
2020) 
Detox/Rehab unit £1114/week 
£154/day 
(Curtis and Burns 2019) 42 
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Appendix 6: Participants’ use of emergency and hospital services, by arm 
 UC (n=32) EC (n=48) 
 n of null 
use 
n (range) when 
use > 0 
Missing n of null 
use 
n (range) when 
use > 0 
Missing 
Baseline n=32 n=48 
A & E 24 7 (1-2) 1 40 7 (1-3) 1 
Of which admitted - 5 yes 2 - 2 yes, 5 no 0 
Outpatient 29 2 (1-1) 1 40 7 (1-10) 1 
Inpatient (nights) 25 6 (1-14) 1 46 1 (1) 1 
Day case 29 2 (1-1) 1 42 5 (1-4) 1 
Ambulance 27 4 (1-2) 1 43 4 (1-2) 1 
4 weeks n=21 n=39 
A & E 16 3 (2-9) 2 34 5 (1-4) 0 
Of which admitted - 2 yes, 1 no 0 - 3 yes, 2 no 0 
Outpatient 20 1 (6) 0 34 5 (1-1) 0 
Inpatient (nights) 19 2 (9-14) 0 37 2 (4-4) 0 
Day case 20 1 (6) 0 35 4 (1-3) 0 
Ambulance 18 3 (3-6) 0 36 3 (1-2) 0 
12 weeks n=18 n=34 
A & E 15 3 (3-6) 0 28 5 (1-2) 1 
Of which admitted - 1 yes, 1 no 1 - 1 yes, 4 no 0 
Outpatient 17 1 (3) 0 30 4 (1-8) 0 
Inpatient (nights) 16 2 (1-8) 0 34 0 (-) 0 
Day case 15 2 (1-3) 1 31 3 (1-2) 0 
Ambulance 16 2 (1-1) 0 34 0 (-) 0 
24 weeks n=12 n=35 
A & E 8 4 (1-4) 0 28 5 (1-6) 0 
Of which admitted - 1 yes, 2 no 1 - 5 no 0 
Outpatient 11 1 (1) 0 33 2 (3-4) 0 
Inpatient (nights) 11 1 (1) 0 34 1 (14) 0 
Day case 10 2 (1-1) 0 29 6 (1-2) 0 
Ambulance 11 1 (2) 0 35 0 (-) 0 
UC: Usual care. EC: E-cigarettes. A&E: Accident and Emergency.  
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Appendix 7: Participants’ use of primary and community services, by arm 
 UC (n=32) EC (n=48) 
 n of null 
use 
n (range) when 
use > 0 
Missing n of null 
use 
n (range) when 
use > 0 
Missing 
Baseline n=32 n=48 
GP 20 11 (1-4) 1 30 17 (1-4) 1 
Practice nurse 23 8 (1-2) 1 40 7 (1-2) 1 
Prescriptions 6 25 (1-12) 1 14 33 (1-16) 1 
Drug/Alcohol 
service 
21 10 (1-30) 1 33 14 (1-9) 1 
Adult mental health 
team 
22 9 (1-30) 1 39 8 (1-4) 1 
Crisis team 27 4 (1-30) 1 45 2 (1-1) 1 
Housing team 22 9 (1-30) 1 35 12 (1-4) 1 
4 weeks n=21 n=39 
GP 10 11 (1-14) 0 29 10 (1-2) 0 
Practice nurse 15 6 (1-4) 0 35 3 (1-1) 1 
Prescriptions 7 14 (1-34) 0 13 25 (1-6) 1 
Drug/Alcohol 
service 
18 3 (2-4) 0 25 14 (1-8) 0 
Adult mental health 
team 
16 5 (1-4) 0 37 2 (1-1) 0 
Crisis team 20 1 (1) 0 39 0 (-) 0 
Housing team 20 1 (1) 0 32 7 (1-4) 0 
12 weeks n=18 n=34 
GP 9 9 (1-5) 0 22 12 (1-5) 0 
Practice nurse 13 5 (1-4) 0 28 6 (1-2) 0 
Prescriptions 5 13 (1-12) 0 14 20 (1-24) 0 
Drug/Alcohol 
service 
18 0 (-) 0 24 10 (1-24) 0 
Adult mental health 
team 
13 5 (1-8) 0 29 5 (1-2) 0 
Crisis team 17 1 (5) 0 33 1 (1) 0 
Housing team 17 1 (1) 0 24 10 (1-8) 0 
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24 weeks n=12 n=35 
GP 3 9 (1-3) 0 22 13 (1-4) 0 
Practice nurse 9 3 (1-3) 0 26 9 (1-3) 0 
Prescriptions 3 9 (1-24) 0 7 28 (1-60) 0 
Drug/Alcohol 
service 
11 1 (1) 0 22 13 (1-26) 0 
Adult mental health 
team 
9 3 (1-24) 0 28 7 (1-6) 0 
Crisis team 12 0 (-) 0 34 1 (1) 0 
Housing team 11 1 (1) 0 25 10 (1-12) 0 
UC: Usual care. EC: E-cigarettes. GP: General practitioner. 
 
 
